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ABSTRACT 
Engineering Heterogeneous Biocatalysis 
Tushar N. Patel 
 
In heterogeneous catalysis, the phase of a catalytic agent, which is responsible for reducing the 
activation energy of a reaction, is different from the phase of its reactants or substrates.  Often, 
soluble catalysts are tightly associated with an inert carrier in order to artificially alter their phase.  
Applying this concept to biocatalysis yields a system in which enzyme molecules are 
immobilized on a solid support.  This often serves to stabilize the enzyme, as well as enhance the 
recyclability of the enzyme since it is no longer soluble.  In this dissertation, two methods of 
enzyme immobilization are evaluated: adsorption to a solid surface and whole-cell biocatalysis.  
The latter is then engineered for improved kinetics and functional activity using principles of 
synthetic biology. 
Adsorption of a protein to a solid surface is driven by the same thermodynamic factors that are 
responsible for the folding of a protein.  Hydrophobic interactions, ionic interactions, covalent 
bonding, and weak forces all contribute to minimizing the free energy of a protein, which defines 
its secondary, tertiary, and quaternary structures.  Upon introduction to a surface, these different 
forces rearrange across the surface of the substrate to minimize the free energy of the system.  
Many factors influence this behavior, including particle curvature, material properties of the 
surface, and the stability of the protein.  In the preexisting body of work, much of the research 
performed regarding the effects of thermal stability on adsorption were performed using mutant 
proteins whose structures were intentionally altered for a range of stabilities. 
In Chapter 2, we evaluate the effects of thermal stability on adsorption behavior using naturally 
evolved enzymes from the AKR superfamily, namely AdhD and hAR.  These enzymes were 
  
selected for their structural homology, but vastly different thermal stabilities.  Using these 
proteins, we demonstrate that the previously held theories of thermostable protein adsorption 
behavior are not entirely applicable to naturally evolved proteins that are not artificially 
stabilized.  We also propose a modification to the classic 4-state adsorption/desorption model by 
introducing new pathways and protein states based on our experiments. 
In addition to physisorption, whole-cell biocatalysis was explored as an enzyme immobilization 
platform.  In general, this can be accomplished by cytosolic expression, periplasmic expression, 
or surface display.  After weighing these options, we chose periplasmic expression in E. coli for 
our biocatalysts.  As for the catalytic component, we selected carbonic anhydrase (CA), a class 
of Zn
+2
-binding metalloenzymes that are capable of catalyzing the reversible hydration of CO2.  
This enzyme was selected for the breadth of applications it can be used for, as well as its 
ubiquity in nature and extremely fast kinetics.  Two isoforms were selected (Cab and Cam) for 
their respective benefits and were periplasmically expressed using 2 different leader peptides, 
which we discuss in Chapter 3.  The enzyme loading in the periplasm, kinetics, thermal stability, 
and functional activity are all reported for the resulting whole-cell biocatalysts.  We also describe 
a new method for the measurement of the operational stability of CA-based biocatalysts. 
Modifications to the whole-cell biocatalysts are described in Chapter 4 and Chapter 5.  In 
Chapter 4, we demonstrate that expression of a viral envelope protein enhances the permeability 
of the outer membranes of E. coli cells.  We characterize this improvement by measuring small-
molecule permeance, whole-cell kinetics, and functional activity of the modified biocatalysts.  
We also quantify this enhancement by applying concepts of porous chemical catalysts to our 
whole-cells.  In doing so, we show improvements in parameters such as the effectiveness factor, 
Thiele modulus, diffusivity, and permeability. 
  
Finally, in Chapter 5 we show enhancement of the functional activity of the whole-cell 
biocatalysts by displaying small peptides on the outer surfaces of the cells.  The modified cells 
are shown to enhance precipitation of calcium carbonate, a common end product of carbon 
mineralization.  Improved solid formation rates are also reported and possible explanations for 
these effects are discussed. 
Overall, this dissertation explores immobilization of enzymes to create heterogeneous 
biocatalysts.  First, the effects of immobilization on enzyme structure, stability, and activity are 
shown for two different immobilization techniques: adsorption to a solid surface and periplasmic 
expression in E. coli cells.  After characterization, engineering of the whole-cell biocatalysts for 
improved properties is presented.  Finally, future directions for this work are discussed which 
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1.1. Heterogeneous Biocatalysis 
For most chemical reactions, catalysts can be used to decrease the activation energy required to 
reach a transition state, a necessary intermediate for product formation.  Enzymes are proteins 
that are capable of catalyzing a wide spectrum of chemical and biochemical reactions.  Due to 
their high substrate specificity, efficiency, kinetics, and biodegradability, enzymes are becoming 
increasingly common in many industries including food processing and the manufacturing of 
cleaning products [1].  Enzymes also have medical applications including the chemical synthesis 
of pharmaceutical intermediates [2] and the treatment of leukemia, jaundice, and blood clots [1].  
Although these enzymes are generally not consumed during the reactions they catalyze, they do 
possess finite lifetimes due to degradation of their active sites, or the protein altogether.  In most 
situations, fresh enzyme would be added to a reaction to account for this loss of activity.  
However, modification of the enzyme to increase its stability has the potential to be a more cost-
effective solution to this issue [1].  Such modifications could include engineering the amino acid 
sequence of the protein to alter its intrinsic stability, which is a common practice, or 
immobilizing the enzyme to generate a heterogeneous biocatalyst. 
In general, a heterogeneous catalyst is one in which the phases of the catalytic agent and its 
reactants are different.  Commonly, the phase of a catalyst can be altered by tightly associating it 
to an inert carrier via covalent attachment, attractive forces, or entrapment.  In terms of an 
enzymatic reaction, this would involve immobilization of the enzyme onto a solid support before 
introduction to a reaction or process.  Heterogeneous biocatalysts have been previously used in 
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industries such as polymer synthesis [3], amino acid synthesis [4], and electrochemical enzyme 
assays [5]. 
Depending on the enzyme and immobilization strategy used, the stability, activity, and 
selectivity of a biocatalyst can all be enhanced [6].  In terms of stability, immobilization can be 
used to increase the operational, storage, and chemical stability of the protein, as well as increase 
its resistance to oxygen or peroxide [7].  Immobilization also facilitates reuse of the biocatalyst 
[1].  Although adding free enzyme to a reactor would result in efficient operation, separation of 
the protein molecules from the reaction solution for reuse would be difficult, time-consuming, 
and expensive.  Immobilizing the enzyme renders it insoluble, which is much more conducive to 
recycling.   
In this work, two immobilization modalities were explored: physical adsorption to a non-
functionalized solid surface, and periplasmic expression in Escherichia coli cells to generate 
whole-cell biocatalysts.  Each of these techniques has their own benefits and drawbacks, as 
outlined below. 
1.2. Protein Adsorption to Solid Surfaces 
The adsorption of proteins to a solid surface is governed by the same interactions that are 
responsible for the secondary, tertiary, and even quaternary structure of a protein.  Hydrogen 
bonding, hydrophobic interactions, disulfide bridges formed between cysteine residues, ionic 
bonds, and weak interactions such as van der Waals forces and Coulomb interactions all 
contribute to protein folding [1, 8].  Upon introduction to a solid surface, a protein’s structure 
will rearrange such that the Gibbs Free Energy (G) of the system is minimized.  In fact, even in 
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the presence of a net repulsive force, a protein will still undergo conformational changes to 
minimize G [9], which is defined as: 
                   (1) 
In general, the adsorption of protein molecules to a surface is entropically driven.  The 
dehydration of hydrophobic domains on the surface, the dissociation of entrained water 
molecules within the protein, and the surface-induced conformational changes experienced by 
the protein all contribute to this term.  Enthalpic driving forces are determined by the 
conformational changes upon adsorption, ion transport to the adsorbed protein, and charge 
rearrangements.  Ion transport and charge redistribution are dependent on the pH, charge 
difference between the adsorbent and protein, and ionic strength of the solution [10].  Also, it has 
been shown that on a bare surface, the adsorption of one protein molecule promotes the 
adsorption of subsequent molecules.  This means that once one protein molecule has adsorbed, a 
cascade of protein adsorption and unfolding is initiated [11].  However, it is still largely 
unknown what properties are responsible for the amount of protein adsorbed and the extent of 
denaturation.  According to the current literature, the two most important factors to consider are 
the curvature of the particles [12, 13] and the stability of the protein [14, 15]. 
Adsorbed proteins can often be desorbed easily with a slight change in ionic strength, pH, or 
even a concentration gradient between the surface and bulk solution.  Since proteins lack 
structural memory, refolding upon desorption will usually stop at a stable intermediate, also 
known as a molten globule state [16].  In such a state, the protein’s structure achieves a local 
minimum in free energy before reaching the global minimum defined by a correctly folded 
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molecule.  This could have significant implications in applications such as therapeutic proteins 
where misfolding could skew the activity, efficacy [17], or toxicity of the protein [18].   
The concepts described above have long been a topic of interest among researchers.  For 
example, it has been previously reported that adsorbed Bovine Serum Albumin (BSA) on silica 
particles showed significant conformational changes, often resulting in a 60% loss in α-helical 
structure.  Upon desorption with a low concentration of morpholine, some of those helical 
domains were restored, but the total helical content was still about 30% less than the native 
structure [9].  This structural rearrangement has previously been shown to translate into losses in 
a protein’s physical and chemical properties including activity [19] and thermal stability [20]. 
Other studies have demonstrated the effects of carrier particle diameter on adsorption behavior.  
Both lysozyme [12] and Human Carbonic Anhydrase I (HCAI) [13] have been shown to be 
susceptible to curvature effects.  In both cases, larger particles with less apparent curvature 
relative to protein size resulted in a higher degree of protein denaturation than smaller particles.  
Further, it has been speculated that larger particles are more conducive to multilayer adsorption 
as opposed to monolayer formation.  This hypothesis was made by comparing the measured 
amount of protein adsorbed to a theoretical amount of protein that would be required to form a 
monolayer [12]. 
Finally, the effects of thermal stability on adsorption behavior were previously studied using T4 
lysozyme (T4L) adsorbed onto silica wafers [21], nanoparticles [15], and planar mica surfaces 
[14].  In these studies, wild-type T4L was compared to mutants I3W, I3C, and I3L in which the 
isoleucine residue at position 3 was changed to tryptophan, cysteine, and leucine, respectively.  
Of these mutants, I3W was the least stable, followed by the wild-type enzyme, I3L, leaving I3C 
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as the most stable mutant.  This is unsurprising since the cysteine substitution allowed for the 
formation of an additional disulfide bridge not present in the wild-type enzyme.  This extra 
covalent bond increased the energy required for denaturation and therefore, the stability of the 
mutant.  The conclusion of all of these studies was that less stable proteins undergo more 
extreme conformational changes in both secondary and tertiary structure [14, 15, 21].  While 
these conclusions appear definitive, there exists a gap in the current literature. 
The studies described above all used artificially stabilized (and similarly destabilized) mutants.  
However, naturally-evolved homologous proteins with similar structures but different thermal 
stabilities have been scarcely used for this type of analysis.  This work addresses this gap using 
the model system described below. 
1.2.1. Model System: Aldo-keto Reductases with Distinct Thermostabilities 
As described above, previous studies that relate thermostability to adsorption behavior have been 
performed, but used engineered mutants of a wild-type enzyme.  Instead of using artificially 
stabilized proteins, the work presented herein used two enzymes from the Aldo-Keto Reductase 
(AKR) Superfamily.  The first is a highly thermostable Alcohol Dehydrogenase D (AdhD) from 
the hyperthermophile Pyrococcus furiosus [22].  The other is a mesostable Aldose Reductase 
(hAR) found in humans [23].  These proteins were selected because of their shared (-barrel 
type crystal structures [24], which confers NAD(P)(H)-dependent activity to most proteins 
containing this scaffold [25].  Almost all of the oxidoreductase enzymes in the AKR superfamily 
exhibit this characteristic structure, despite low primary sequence homology across the various 
proteins.  Since the only significant difference between AdhD and hAR is their thermal stabilities, 




1.3. Whole-Cell Biocatalysis 
In contrast to physically adsorbing a protein onto a solid surface, whole-cell biocatalysts are in 
large part self-assembled where the host cell that expresses a protein also becomes its carrier.  
This provides a distinct advantage over adsorption or other immobilization techniques because 
protein purification, which is often a very time-consuming and expensive process, is not 
necessary.  Also, solid supports onto which the enzymes are to be immobilized are no longer 
required, offering an additional cost benefit.  Whole-cell biocatalysts have been previously 
shown to be viable for applications such as the production of biofuels [26], chiral alcohols [27], 
and L-amino acids [28], among others.  Most commonly, these biocatalysts are generated by 
recombinant overexpression of an enzyme within the cytosol [26], the periplasm of gram-
negative bacteria such as Escherichia coli [29], or on the exterior surface of the cell [30].  
However, native cells have also been previously used as whole-cell biocatalysts [31].  Cytosolic 
expression is most easily achieved by simply cloning the gene encoding the protein of interest 
into an expression vector, of which there are a large number available.  Periplasmic expression 
can be achieved by fusing the desired protein to a signaling peptide or periplasmic protein in 
order to direct it to the periplasm [32].  If desired, the fusion can either be cleaved or left intact 
after translocation.  Surface display can be achieved by a number of different means [33].  One 
of the most common methods is fusion of the protein of interest to a transmembrane protein such 
that the recombinant protein is exposed to the extracellular matrix [32].  Each of these methods 
possesses their own limitations and advantages which must be balanced when selecting an 
immobilization method. 
Initially, it would appear that surface display would be the most attractive method of whole-cell 
heterogeneous biocatalysis since the enzyme has direct access to its substrate(s) and cofactor(s) 
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with little chance of local product accumulation.  However, this technology is not without 
limitations.  Activity losses, difficulties with displaying multiple proteins at once, and difficulties 
with multi-subunit proteins are all challenges associated with the use of surface display [34].  
Further, low expression levels and exposure to the extracellular space could be potential 
limitations of this technique. 
Of the two intracellular compartments, expression in the cytosol generally results in the highest 
levels of protein expression.  The cytosol is also a favorable environment for most proteins, so 
proper folding is almost guaranteed [35].  Periplasmic expression, on the other hand, has slightly 
lower yields and is an oxidative environment, which may not be conducive to the correct folding 
of all proteins [35, 36].  However, since the periplasm constitutes a small portion of the total cell 
volume (~10% [37]), a high degree of crowding within this space is assumed.  This could result 
in unfavorable entropic penalties for protein unfolding, thus stabilizing the recombinant enzymes. 
The main limitation to using whole-cell biocatalysts generated by either cytosolic or periplasmic 
expression is the reduction in catalytic efficiency as a result of mass transport limitations across 
the semi-permeable cell membranes.  It has been reported that the reaction rate of a whole-cell 
biocatalyst can be up to 2 orders of magnitude slower than the free enzyme.  This limitation 
could cause an accumulation of product within the cell, which in some cases could lead to 
product inhibition [38].  Thus, whole-cell biocatalysts generated by intracellular expression are, 
in general, diffusion-limited. 
While recombinant enzyme expression in either of the two cellular compartments is subject to 
this transport limitation, periplasmic expression is slightly more favorable in this regard.  For a 
periplasmically expressed enzyme, the required substrate(s) and/or cofactor(s) need only diffuse 
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across the cell’s outer membrane, as opposed to both the outer and inner membrane, as with 
cytosolic expression.  Similarly, the product(s) formed by the catalyzed reaction can diffuse out 
of the periplasm more easily, thus reducing the effect of product inhibition. 
In this work, whole-cell biocatalysts for the hydration of CO2 were generated via periplasmic 
expression of carbonic anhydrase.  These biocatalysts were characterized and modified for 
improved properties. 
1.3.1. Model System: Carbonic Anhydrase 
Carbonic anhydrases (CA) are Zn
+2
-binding metalloenzymes that are nearly ubiquitous in nature; 
almost all living organisms produce at least one form [39, 40].  The primary function of these 
enzymes is the reversible hydration of CO2, accomplished via the bound Zn
+2
 ion [41].  These 







[42].  Potential inhibitors for these enzymes include monovalent anions that 
nonspecifically bind to the active site, sulfonamides, which bind to the metal atom preventing its 
association with a water molecule, imidazole, which will weakly compete with CO2 [39], and 
topoiramate, which infiltrates the active site of human carbonic anhydrase [43].  CA enzymes 
can be divided into three main classes: -, -, and -class.  The -class contains all mammalian 
and E. coli isoforms, as well as two enzymes from the algal species Chlamydomonas reinhardtii 
[42].  The -class is comprised of isoforms from all plants [44], Neisseria gonorrhoeae, and 
Methanobacterium thermoautotriphicum [45].  Finally, the only enzyme currently belonging to 
the -class is natively found in Methanosarcina thermophila.  This enzyme exhibits a left-handed 
-helix fold, which is not present in any other carbonic anhydrase [42, 46].  Potential 
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applications for these enzymes include carbon capture [47], engineered photosynthesis [48], 
biofuel production [49], and electrochemical biosensors [50]. 
Due to the ubiquity of these enzymes, two were selected for investigation within this work: Cab 
(Methanobacterium thermoautotriphicum; PDB: 1G5C) and Cam (Methanosarcina thermophile; 
PDB: 1THJ).  Cab is a -type CA and is among the most thermostable isoforms ever discovered 
[42].  Cam is the γ-type CA described above and while less thermally stable than Cab, it is 
natively expressed in the periplasm, which insures its efficacy in an oxidative environment [51].  




, which puts them among the slower 
forms of CA, but still incredibly fast relative to other families of enzymes [45].  Due to the 
distinct advantages each isoform exhibits, these two enzymes were selected to generate whole-
cell biocatalysts via periplasmic expression. 
1.4. Research Goals 
Heterogeneous biocatalysis harbors great potential for use in industrial and research applications, 
as discussed above.  Immobilization of an enzyme can increase its stability, and enhance its 
recyclability by rendering it insoluble.  In this research, the main goals were to evaluate various 
immobilization techniques, and to engineer an efficient and stable heterogeneous biocatalyst.  
The specific scientific and engineering goals undertaken in this endeavor are outlined below, 
along with their corresponding chapters within this thesis: 
Goal 1: Investigate the effects of inherent thermostability on protein adsorption to a solid 
surface 
This goal is addressed in Chapter 2, in which AdhD and hAR were used to determine if native 
thermal stability changes the adsorption behavior of proteins with similar secondary structures.  
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To do so, Langmuir adsorption isotherms, circular dichroism (CD), and standard NAD(P)(H) 
activity assays were used to characterize the proteins in their native, adsorbed, and desorbed 
states. 
Goal 2: Create and characterize whole-cell biocatalysts possessing CA activity 
This goal is addressed in Chapter 3, where Cab and Cam were periplasmically expressed in E. 
coli and characterized using quantitative western blotting, stopped-flow spectroscopy, and a 
calcium carbonate precipitation assay to demonstrate their potential for use in an industrial 
application.  Further, the thermal stabilities of free and immobilized enzymes were determined 
and compared.  Finally, a new method for measuring the operational stability of CA-based 
biocatalysts, a technology surprisingly scarce in current literature, was developed and used to 
evaluate the various biocatalysts. 
Goal 3: Engineer the outer membranes of the whole-cell biocatalysts for enhanced 
kinetic activity 
In Chapter 4, the outer membrane of each biocatalyst was permeabilized via recombinant 
expression of a viral protein known to increase permeability in E. coli.  These modified 
biocatalysts were then evaluated using stopped-flow spectroscopy, a membrane-permeability 
assay, and the carbonate precipitation assay.  These permeabilized cells were then subjected to 
quantitative characterization using principles of porous catalysts to determine the improvements 
in various reaction-diffusion parameters. 




In Chapter 5, the outer surfaces of the biocatalysts were functionalized with small peptides to 
enhance the precipitation of carbonates, which again demonstrated their potential for use in an 
industrial application.  In order to do so, the peptides were fused to a version of a native 
transmembrane protein engineered to display both of its termini to the extracellular space.  
Successful expression of these fusions was confirmed by Flow Cytometry.  Their effectiveness 





2. Immobilization via Adsorption: The Effects of Intrinsic Thermal 
Stability 
 
Note: A version of this chapter entitled “Effect of thermal stability on protein adsorption to silica using homologous aldo-keto reductases.” is 
published in Protein Science (2012), volume 21, issue 8, pages 1113-1125, with co-authors Flora Felsovalyi, Paolo Mangiagalli, Sanat K. Kumar, 
and Scott Banta. 
 
TNP cloned the hAR construct, collected and analyzed the hAR data, and assisted in the writing of the manuscript. 
2.1. Abstract 
 
Gaining more insight into the mechanisms governing the behavior of proteins at solid/liquid 
interfaces is particularly relevant in the interaction of high-value biologics with storage and 
delivery device surfaces, where adsorption-induced conformational changes may dramatically 
affect biocompatibility. The impact of structural stability on interfacial behavior has been 
previously investigated by engineering non-wild-type stability mutants. Potential shortcomings 
of such approaches include only modest changes in thermostability, and the introduction of 
changes in the topology of the proteins when disulfide bonds are incorporated. Here we employ 
two members of the aldo-keto reductase superfamily (alcohol dehydrogenase, AdhD and human 
aldose reductase, hAR) to gain a new perspective on the role of naturally occurring 
thermostability on adsorbed protein arrangement and its subsequent impact on desorption. 
Unexpectedly, we find that during initial adsorption events, both proteins have similar affinity to 
the substrate and undergo nearly identical levels of structural perturbation. Interesting differences 
between AdhD and hAR occur during desorption and both proteins exhibit some level of activity 
loss and irreversible conformational change upon desorption. Although such surface-induced 
denaturation is expected for the less stable hAR, it is remarkable that the extremely thermostable 
AdhD is similarly affected by adsorption-induced events. These results question the role of 




Over the past few decades, extensive focus has been applied to understanding the mechanisms 
governing the behavior of proteins at solid/liquid interfaces. Due to wide-spread implications of 
this phenomenon in numerous applications, a large number of systems have been studied. To 
gain more insight into how protein structure affects interfacial behavior, the importance of 
surface charge [52, 53], hydrophobicity [54], and structural stability [14, 55] have been 
investigated. 
Approaches to study the effects of these parameters can be categorized as follows: the study of 
well-defined model proteins [8, 56-59], genetic variants [60, 61], mutants of single proteins [15, 
21, 62], and most recently, synthetic polypeptides [63-65]. Significant effort in the two former 
categories has pioneered our overall understanding of the mechanisms governing protein 
adsorption; however, it is the latter groups in which the effect of subtle molecular effects can be 
assessed. Thus, ideal studies could be envisioned in which a single parameter, such as stability or 
surface charge, are studied in isolation.  
Many of these studies have explored the structural consequences of adsorption. Elbaum  [66] 
used stability variants of hemoglobin to hypothesize a strong structural basis for observed 
differences in adsorption kinetics and protein unfolding at the air/water interface. Kato [67] 
strengthened this correlation between conformational stability and interfacial affinity and level of 
surface-induced perturbation using tryptophan synthase mutants. More recently, bacteriophage 
T4 lysozyme has been the protein of choice for similar studies because it is extremely well 
characterized and synthesis of stability mutants is well documented. McGuire [62] created T4 
variants with enhanced stability by introducing cysteine residues to form additional intra-
molecular disulfide linkages. Following the kinetics of adsorption and elutability, they postulated 
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a correlation between protein stability and time-scale of attachment and binding strength. CD 
spectroscopy revealed that both the rate and extent of unfolding (characterized by α-helical loss) 
upon adsorption to silica nanoparticles was most pronounced for the least stable mutants [55]. 
The general hypothesis emerging from these studies is a strong correlation between 
thermostability and affinity of surface attachment, structural perturbation and desorbability. 
However, there are two potential shortcomings with the application of stability mutants to 
evaluate surface activity. First, only incremental changes in stability can be assessed. The range 
of stabilities is limited by the number of residue substitutions which alter stability without 
impacting secondary structure. Second, stability is artificially optimized in these systems. For 
example, common approaches involve strategically placed disulfide bonds or the insertion of 
residues with side chains that cause steric disruptions in critical locations. However, these 
approaches change the topology of the peptide chain and it is difficult to decouple the effect of 
the stability-altering mutations from the effect on protein-surface interactions.  
The goal of our investigation is to explore the relationship between stability and adsorption 
behavior using naturally evolved homologs with very similar 3-D structures yet vastly different 
intrinsic stabilities.  We have chosen two members of the aldo-keto reductase (AKR) superfamily 
[24] which share high structural homology with low primary sequence homology (Figure 2-1).  
The members of the AKR superfamily are monomeric, do not contain disulfide bonds, and fold 
into well-known 8 stranded, TIM-like, α/β barrels. The first enzyme, alcohol dehydrogenase D 
(AdhD) from the hyperthermophilic archaea Pyrococcus furiosus, is highly thermostable [22, 68] 
while the second enzyme, human aldose reductase (hAR), is mesostable [23].  We believe this is 
the first time that homologous stability variants have been used to explore the effects of protein 
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stability on interfacial behavior. Adsorption and desorption were investigated using a hydrophilic 
silica surface which was previously used in adsorption studies of model proteins [9, 69, 70].  
Based on previous results, we hypothesized that AdhD and hAR would exhibit different 
adsorption behavior due to their drastically different thermostabilities. Unexpectedly, our results 
indicate that both proteins have similar affinities to the substrate and undergo nearly identical 
levels of structural perturbation. Interesting differences between AdhD and hAR are observed 
during desorption, with respect to elutability, refolding pathways and distribution of desorbed 
structural states. Both proteins exhibit some level of activity loss and irreversible conformational 
change upon desorption. Although surface-induced denaturation and activity loss is expected for 
the less stable hAR, it is remarkable that AdhD, which retains native-like structure and activity at 
even at 100
○
C, is significantly affected by adsorption-induced events. Therefore, our results 
suggest that intrinsic structural stability may not be the most accurate predictor of adsorption 
behavior, and that other predictors, such as electrostatics, may have a greater impact on the 
extent of surface affinity and unfolding. These results may call into question the commonly held 
belief that increasing thermostability should reduce surface activity. 
2.3. Materials and Methods 
Materials.  DNA oligonucleotides were synthesized by Integrated DNA Technology (IDT; 
Coralville, IA).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) was obtained from Promega 
(Madison, WI).  Fumed colloidal silica particles (Cab-o-sil M-5, <99.8% purity) were purchased 
from Cabot Corp. (Boston, MA) and used without further treatment.  Bicinchoninic acid (BCA) 
and QuantiPro BCA Assay kits were purchased from Thermo Fisher Scientific (Rockford, IL).  
Restriction enzymes NcoI and HindIII, T4 DNA Ligase, and Phusion DNA Polymerase were 
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purchased from New England Biolabs (Ipswich, MA).  All other chemicals were obtained from 
Sigma-Aldrich (St. Louis, MO). 
Cloning.  The hAR gene was amplified from human placental cDNA (Clontech, Mountain View, 
CA) using overlap extension PCR to eliminate an internal NcoI restriction site present in the 
hAR gene.  Detailed information about the primers can be found in the Supplementary 
Information (Section 2.8).  The purified PCR fragment was doubly digested and ligated into a 
similarly digested pET-24d (Novagen, Gibbstown, NJ) vector containing a poly-His tag.  Ligated 
plasmids were electroporated into BLR E. coli cells (Novagen) and selected on LB agar plates 
supplemented with 50 ng uL
-1
 kanamycin.  Colonies were grown in terrific broth (TB) with 50 
ng uL
-1
 kanamycin and stored as glycerol stocks at -80
o
C.  The correct insertion of the hAR gene 
was verified by DNA sequencing. 
Protein Purification.  AdhD from the hyperthermophilic archaea Pyrococcus furiosus was 
expressed and purified as previously described [68].  hAR was expressed and purified as follows. 
Following transformation, the cells were induced at OD600 of 0.6 with 0.2mM IPTG.  After 
incubating 18 hours at 37
o
C with agitation, the cells were harvested by centrifugation.  The 
pelleted cells were resuspended in one-tenth of the expression volume in 20 mM Tris-HCl, 150 
mM NaCl, and 40 mM imidazole (pH 7.5) and supplemented with 1x HALT protease inhibitor 
cocktail (Thermo-Fisher).  The cells were lysed by sonication with an 8 minute run time with 
pulses of 5 seconds with a 5 second rest between each pulse.  The cell debris was pelleted by 
centrifugation at 15,000xg for 30 minutes.  The hAR was purified from the clarified lysate using 
a HisTrap column (GE Healthcare) on a GE ÄKTA FPLC.  The fractions containing hAR, 
(verified by SDS-PAGE) were pooled and concentrated using Amicon (EMD Millipore) 





Protein Concentration.  Concentrations were determined by UV absorbance at 280 nm and the 
BCA total protein assay (Macro assay: 1-0.025 mg mL
-1
; Micro assay: 0.05-0.0005 mg mL
-1
).  
Absorbance measurements were conducted on a SpectraMax M2 spectrophotometer (Molecular 




) and hAR 




) were measured experimentally.  Preparation of standards for the BCA 
assays and protein samples for extinction coefficient measurements are described in the 
Supplementary Information (Section 2.8).  
Activity Assay.  The 2,3-butanediol oxidation activity of AdhD and DL-glyceraldehyde reduction 
activity of hAR were measured using spectrophotometric assays under saturation conditions.  
NAD
+
 and NADPH were used as cofactors for AdhD and hAR, respectively.  For AdhD, the 
absorbance at 340 nm (tracking NAD
+
 reduction) was measured at 45
o
C with final 
concentrations of reaction buffer (glycine, pH 8.8), substrate and cofactor of 50 mM, 100 mM, 
and 1 mM, respectively.  For hAR, the absorbance at 340 nm (tracking NADPH oxidation) was 
followed for reactions at 25
o
C with concentrations of reaction buffer (sodium phosphate, pH 7.0), 
substrate and cofactor of 100 mM, 100 mM, and 0.5 mM, respectively.  Raw absorbance change 








Adsorption Isotherms.  Silica particles were suspended in 20 mM sodium cacodylate buffer pH 
5.0 (AdhD) or pH 6.9 (hAR) to achieve a concentration of 12 mg mL
-1
.  Equal parts of protein 
solution and silica suspension were mixed.  Protein concentrations of 0.1-6 mg mL
-1
were 
achieved by diluting with 20 mM Tris pH 7.5.  Final pH resulted in 5.7 for AdhD and 7.2 for 
hAR.  The samples were rotated on a rotisserie shaker for 16 hours at room temperature.  
Supernatants were collected and surface coverage was calculated as described previously [17].  
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Desorption.  After removal of the supernatant, the particle pellet was resuspended in 0.8 mL of 
10 mM sodium cacodylate buffer pH 5.0 (AdhD) or pH 6.9 (hAR).  Samples were weighed to 
determine the particle loss over time.  A solution density of 1.02 g cm
-3
 was used to determine 
the resuspension volume.  After resuspension, the samples were incubated on a rotisserie shaker 
for 30 minutes.  Then, supernatant was collected in the same as in the adsorption experiments.  
Resuspension was repeated for a total of 10 supernatants, from which a desorption curve was 
obtained.  It was assumed that by the third resuspension cycle all of the protein had interacted 
with the particles, and these samples were used for CD and kinetic activity evaluation.  
Circular Dichroism.  A Jasco J-815 CD spectrometer (Jasco, Inc., Easton, MA) equipped with a 
Peltier junction temperature control was calibrated with 0.06% d-10-camphorsulfonate solution 
and used for far-UV CD measurements.  Quartz cuvettes with path lengths of 0.01, 0.02, 0.05, or 
0.1 cm were used.  Protein solutions and protein-particle mixtures were measured using buffer or 
silica blanks, respectively, for subtraction of the baseline signal.  Measurements were taken from 
185 to 240 nm with a 0.1 nm interval, 1 nm bandwidth, 8 second response time, and scanning 
speed of 50 nm min
-1
.  For desorbed protein structure, the 0.1 cm cuvette was used, and the scan 
was cut off at 200 nm due to buffer interference.  For each sample, 3 accumulations were 
measured and averaged.  Raw CD signal (θ) was converted to Mean Residue Ellipticity (MRE) 
using the equation: 
[ ]    
 
       
 (1) 
where Cr is the protein concentration (M*residue number) and l is the cuvette path length (cm). 
Measurement of Adsorbed Protein Structure.  The pellets from the adsorption isotherm were 
resuspended with gentle pipetting using a 1:1 mixture of 20 mM Tris-HCl pH 7.5 and 20 mM 
sodium cacodylate pH 5.0 (AdhD) or pH 6.9 (hAR).  An aliquot was removed for CD assessment, 
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and the rest of the solution was pelleted through centrifugation (as described above) and 
supernatant concentration measured.  The CD spectra of the supernatant were also recorded.  
Using the known amount of adsorbed protein, concentration in the resuspended pellet was 
determined.  Using the MRE signals of the resuspended pellet ([θ]pell) and supernatant ([θ]SN), 
and the fraction of total protein concentration in the supernatant (χSN), the adsorbed protein 
structure was calculated using: 
[ ]    
[ ]         [ ]  
     
 (2) 
Deconvolutions.  The CD spectra were deconvoluted using the CD Pro software package [71].  
With each deconvolution algorithm (Continll, Selcon3, and Cdstr), 3 different reference sets 
were applied: SP37, SPD42, and SMP50.  The average across all 3 algorithms and 3 bases are 
used to estimate the helical, sheet, and disordered content of each sample.  The α-helix and -
sheet content is reported as the sum of the distorted and regular classes. 
Electrophoretic Mobility. A Malvern Zetasizer Nano-ZS was used to measure particle size 
distribution and zeta potential of the silica particle suspensions in the pH = 5.7 and pH = 7.2  
Tris/cacodylate buffers, or protein-silica mixtures.  A 50 mW laser operating at a wavelength of 
532 nm was used.  Scattering intensities were recorded at a 90
o
 angle.  A clear, disposable zeta 




Structural Characterization of Model System.  Two homologous AKR superfamily members, 
AdhD and hAR, were chosen due to their similar secondary structures and different intrinsic 
structural stabilities.  The sequence alignment (ClustalW2, EBI; Figure 2-1A) and ribbon 
structures (Figure 2-1B) show that while there is low sequence homology (<30%) between the 
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proteins, the tertiary structures are very comparable.  Overlaying the CD spectra for both proteins 
more clearly demonstrates these similarities (Figure 2-1C).  The high degree of spectral overlap 
indicates similar proportions of α-helical and -sheet content.  The fraction of secondary 
structure assigned to various domains from primary sequence predictions, the homology model 
(AdhD) or crystal structure (hAR; PDB: 2ACQ), and deconvolution of CD spectra are tabulated 
in Table 2-1.  For both proteins, the fractions of secondary structure assigned to the helix and 
sheet domains are similar between the sequence prediction and homology model, but there is a 
discrepancy compared to experimental deconvolution values. This discrepancy is explained 
further below.  However, the similarity in each secondary structure domain of the two proteins, 
with all three enumeration methods, is obvious from the table.  The CD-based method was used 
as the principle experimental tool to assess relative changes in secondary structure.  While the 
CD data demonstrate the similar structures of the proteins, the significant difference in structural 
stability is demonstrated by the melting curve shown in Figure S2-2, where the CD signal at 
222nm (indicative of helical content) is measured over a thermal excursion from 25 to 95
o
C.  
The curve shows that hAR loses a considerable amount of helical structure, while AdhD is 
minimally affected and no noticeable unfolding occurs below 95
o
C. 
Adsorption Behavior.  The surface coverage of protein molecules adsorbed to the nanoparticles 
following a 16 hour isothermal incubation period is plotted against the equilibrium (supernatant) 
concentration (Figure 2-2).  For both proteins, there are three well-defined regions: a rising linear 
portion, a transition region, and a maximum coverage plateau.  At least one point from each of 
these regions is represented in subsequent data sets (letters in Figure 2-2 indicate these 





       
     
 (3) 
where Γ is surface coverage, Γmax is plateau surface coverage, Ceq is equilibrium protein 
concentration, and K is the apparent dissociation constant.  Although assumptions underlying the 
Langmuirian model are not all necessarily appropriate for the adsorption of complex 
biomacromolecules (absence of conformational change and lateral interaction on the surface), the 
model describes this high-affinity protein-surface interaction well.  The maximum surface 
coverage and affinity obtained from this fit are 1.68 mg m
-2
 and 0.50 mg mL
-1
 for AdhD, and 
2.40 mg m
-2
 and 0.35 mg mL
-1
 for hAR, respectively. The lower affinity coefficient and higher 
maximum surface coverage of hAR, as compared to AdhD, indicate an increased affinity and 
adsorbed amount.  Based on the molecular volume of each protein, theoretical surface coverages 
of 2.20 and 2.26 mg m
-2
 for AdhD and hAR, respectively, were obtained.  In order to account for 
the packing of molecules on the surface, the Random Sequential Adsorption (RSA) [72] packing 
density (ϴ=0.547) was multiplied by the total surface area of the particles to obtain the available 
surface area [73].  Since these calculations only account for size and not intermolecular 
interactions, the variance from experimental values is not concerning. 
Adsorbed Protein Structure.  Figure S2-3 shows the CD spectra of the different populations of 
proteins following surface interaction.  A combination of these spectra was used to calculate 
adsorbed protein spectra.  Figure 2-3 shows the adsorbed spectra for 5 different coverages for 
AdhD (Figure 2-3A) and hAR (Figure 2-3B).  Two important conclusions emerge from these 
plots: first, for both proteins, the adsorption induces a significant level of unfolding compared to 
native; and second, the adsorbed spectra do not vary significantly as a function of surface 
coverage.  To further compare the level of unfolding that occurs upon adsorption, all spectra 
were deconvoluted and the results can be seen in Figure 2-3C.  The tabulation of these results 
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can be found in Table S2-2.  The results show that both surface-bound proteins converge on 
similar α-helical (~0.06) and -sheet (~0.35) content. 
Desorption Behavior.  The pellets obtained from the protein-particle mixtures were resuspended 
in fresh buffer to induce desorption.  Previously, eluents such as morpholine [9] or 
dodeclytrimethylammonium bromide [53] were used to desorb bound proteins.  In this study, we 
relied on the protein concentration gradient between the surface and bulk as the driving force for 
desorption.  Introducing fresh buffer creates a transient difference in chemical potential (Δµs) at 
the interface, which is then eliminated by spontaneous desorption.  Following resuspension and 
incubation of the particles, the supernatant protein concentration was measured, which represents 
the desorbed amount.  This sequence of resuspension and supernatant collection was repeated for 
10 cycles for each protein (Figure 2-4A and Figure 2-4B).  Data with varying protein:particle 
ratios were collected to assess the effect of coverage on desorption.  The most striking difference 
in behavior between the two proteins is that the desorbed amount is affected by surface coverage 
much more significantly for hAR (Figure 2-4B) than the AdhD (Figure 2-4A).  For AdhD, there 
is only a slight decrease in desorbed amount as coverage decreases, while for hAR, desorbed 
amount varies by over an order of magnitude for the lowest coverage shown, 0.08 mg m
-2
, than 
for coverages above 0.52 mg m
-2
.  This indicates the propensity to desorb is decreased when 
fewer proteins coat the surface.  A more subtle difference between the two desorption curves is 
that while desorbed amount levels off after the third cycle for hAR, this decreases continuously 
from cycle-to-cycle for AdhD.  This indicates that the arrangement of particles for hAR reaches a 
steady state value earlier in the experiment, while for AdhD a possible redistribution on the 
surface manifests as a variability of the desorbed amount from cycle-to-cycle.  Also, because 
elutability is expected to increase with molecular weight [59], the higher concentration values of 
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hAR in the supernatant after cycle 5 are consistent with this hypothesis (MWhAR=37.2 kDa, 
MWAdhD=31.9 kDa).  
To adsorption/desorption reversibility, surface coverage following each rinse cycle is calculated 
and desorption isotherms are created, as shown in Figure 2-4C (AdhD) and 4D (hAR).  In these 
figures, the lines represent the Langmuir fits of the adsorbed data (solid line) and desorbed data 
(dashed line).  For AdhD, all six desorbed data sets are used for the Langmuir fit, as each group 
follows similar trends. This desorption curve in Figure 2-4C varies distinctly from the adsorption 
isotherm.  For reversible adsorption, the ascending and descending branches of the isotherm 
must overlap at all values of Ceq.  Therefore, our results indicate irreversible adsorption, and also 
coverage-dependent desorption (namely a path-dependent hysteresis of desorption).  Conversely, 
two desorbed populations are found for hAR: at higher coverages (corresponding to transition 
and plateau values), a single Langmuirian desorption curve can be fit to all the data sets.  As 
before, this desorption curve (Figure 2-4D) deviates significantly from the adsorption isotherm, 
indicating non-reversible adsorption.  At low coverages (below 0.53 mg m
-2
), two data sets 
reside in a different desorption regime as seen from their position relative to the Langmuir 
desorption curve.  Interestingly, these data sets align closely with the Langmuir adsorption curve. 
Desorbed Protein Characterization.  To characterize secondary structure of the desorbed protein, 
far-UV CD spectra were taken from the third resuspension cycle.  Native and desorbed protein 
spectra are shown in Figure 2-5.  Three different coverages (corresponding to the plateau, 
transition and rising portions of the adsorption curve) are shown for the desorbed protein.  The 
results are consistent with the previously described desorption curves: for AdhD (Figure 2-5A), 
little variation exists for desorbed protein structure with coverage, while for hAR (Figure 2-5B), 
the structure at lower coverages is severely perturbed compared to the higher coverages.  The 
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results also show that all desorbed samples are slightly less structured than native for AdhD, 
while there is practically no difference between the high-coverage desorbed spectra and native 
hAR. 
Activity assays were also performed on the same desorbed protein populations.  The 2,3-
butanediol oxidation activity of AdhD using NAD
+
 cofactor and the DL-glyceraldehyde 
reduction activity of hAR using NADPH as cofactor were measured.  The results of the kinetic 
assays are shown as percent of native activity in Figure 2-6.  The specific activities are also 
reported in Table S2-3.  These activity results correlate well with the secondary structure 
characterization.  For AdhD, all desorbed protein, independent of surface coverage, lose ~35% 
native activity.  In contrast, for hAR, the four high-coverage samples, which were grouped 
together earlier based on lack of secondary structural modification upon desorption, have no 
apparent activity loss upon desorption.  However, the lower coverage samples, which were found 
to be severely perturbed by CD, show ~80% activity loss. 
2.5. Discussion 
Because proteins are naturally surface-active, adsorption can act as a catalyst to induce structural 
alteration, activity loss, or aggregation.  Preventing such undesired surface-induced effects 
requires a fundamental understanding of the role of intrinsic protein parameters in adsorption 
behavior.  Such knowledge is especially relevant in the pharmaceutical industry, where 
biologically-active therapeutic agents contact numerous surfaces during manufacturing, storage 
and delivery.  During drug development, extensive effort is dedicated to improve the stability of 
such proteins, as various types of degradation pathways compromise their safety and efficacy.  
Although surface adsorption is not traditionally considered among the most common causes for 
physical instability, this phenomenon has been documented as a catalyst for denaturation [74].  
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Designing greater stability into proteins is thought to be a key strategy to mitigate such surface 
effects [75, 76]. 
It has long been recognized that a protein’s structural stability influences its interfacial behavior, 
as the presence of a surface can disrupt intermolecular forces and render the protein susceptible 
to adsorption-induced conformational changes.  In previous studies, this role of thermostability 
has been studied using engineered stability variants.  Although using point mutations allows very 
specific changes to artificially stabilize (or destabilize) the protein without significantly changing 
its tertiary structure, we believe applying these systems in adsorption studies have inherent 
limitations.  Only a limited range of thermostabilities can be studied and the approach used to 
alter stability often changes protein topology.  Along these lines, artificially stabilized mutants 
may have other attributes that would not be favored in naturally evolved systems.  To overcome 
these limitations, we assess the role of thermostability using naturally-evolved homologs.  
Additionally, we significantly expand the range of surface coverages previously explored.  
As shown in Figure 2-1, the use of AdhD and hAR is a fitting model system for the study of the 
effect of naturally-occurring stability.  These two proteins have similar tertiary structures but 
vastly different thermostabilities: hAR loses approximately half of its helical content at 57ºC, 
while AdhD is practically unaffected even at 95ºC.  Regarding structural similarity of the 
proteins, it must be noted that Table 2-1 shows some discrepancies between secondary structure 
fractions determined theoretically from sequence prediction algorithms and direct CD 
measurement followed by spectral deconvolution.  Although the two approaches result in similar 
trends in distribution of secondary structure, the CD-derived results are lower than the theoretical 
values. This is likely due to the inherent limitations of deconvolution algorithms used to quantify 
secondary structure [77].  Although such issues have been documented, CD remains a powerful 
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tool for evaluating comparative structural changes [78, 79] and was used here to examine 
changes in protein structure upon adsorption/desorption. 
The difference in thermal stabilities of the two enzymes could be due to many factors. One 
possible explanation is that since AdhD has a more compact structure, there is more potential for 
close-range interactions that will stabilize its conformation.  Another contributing factor could be 
the fraction of amino acids assigned to different secondary structure motifs.  For example, AdhD 
and hAR have 118 and 112 amino acids involved in alpha-helices, respectively.  However, 
because AdhD has an overall lower residue count than hAR this corresponds to 42% amino acids 
assigned to helices (vs. 34% for hAR). This means that a larger fraction of AdhD is made of a 
motif that contains a high number of hydrogen-bonds per amino acid, which could translate into 
increased intrinsic thermal stability. 
In this study, we chose hydrophilic, unmodified silicon dioxide nanoparticles as the surface for 
several reasons.  On hydrophilic surfaces, in the absence of strong electrostatic forces, protein 
stability is a key parameters that determines surface activity, as structural rearrangement is the 
main entropic driving force favoring adsorption [9, 80].  Colloidal silica also has favorable size, 
refractive index and light scattering properties, which render the particles CD-compatible, 
allowing in-situ structural analysis during adsorption.  A final benefit of using colloidal system is 
our ability to target a wide range of surface coverages.  This is a key parameter for our system of 
interest: proteins in delivery devices, where therapeutic concentration can vary by orders of 
magnitude.  Thus, relevant coverages extend to the plateau region of the adsorption isotherm [17].  
To minimize and normalize the effect of electrostatics, experiments were performed at a pH 
slightly greater than the isoelectric point of each protein, (AdhD pI 5.5, hAR pI 6.9; system pH 
5.7 for AdhD and 7.2 for hAR) thus imparting a slight positive charge, which is consistent for 
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both proteins.  The sodium cacodylate buffer (pKa 6.3) was selected as its effective buffering 
range was compatible with the desired conditions. The silica particles used are negatively 
charged in both systems (pzc 3.0).  
Our results shed new light on the relative role of structural stability in the different kinetic 
processes depicted in Figure 2-7.  During surface attachment (Step I, Figure 2-7), the Langmuir 
curves in Figure 2-2 compare the surface affinity and adsorbed amounts of hAR and AdhD. 
Although we anticipated hAR to have a significantly greater affinity for the surface due to its 
lower thermostability, we find its K value is comparable to that of AdhD.  Similarly, the 
differences in maximum surface coverage can most likely be attributed to the size difference 
between the proteins.  Therefore, these results indicate structural stability does not play a 
significant role in protein-surface attachment.  Figure 2-3 shows hAR and AdhD exhibit similar 
structural transitions on the surface (Step II, Figure 2-7).  While both proteins undergo 
significant structural perturbation, the extent of α-helical loss and concomitant -sheet formation 
is nearly identical.  Although such disruption of intermolecular forces upon adsorption was 
expected for hAR, it is remarkable that the extremely thermostable AdhD undergoes such drastic 
conformational changes on a hydrophilic surface.  Another interesting finding is the lack of 
correlation between surface coverage and structural denaturation for either protein (Figure 2-3C).  
Coverage-dependence of adsorption-induced unfolding has been reported previously [9, 11].  
The results of this study reveal differences between hAR and AdhD during detachment and 
refolding (Steps III and IV, Figure 2-7).  The desorption isotherms (Figure 2-4C and Figure 2-
4D), and structural (Figure 2-5) and kinetic (Figure 2-6) characterization of the desorbed states 
indicate that while adsorption is irreversible in both cases, desorption follows different pathways 
for hAR and AdhD.  For AdhD, some of the structural loss incurred upon adsorption is regained 
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upon detachment, however native-like refolding is not complete and ~35% enzymatic activity is 
lost.  These findings re-emphasize the surprising effect adsorption-induced instabilities have on a 
thermally stable protein.  AdhD also exhibits hysteresis in its refolding pathways as shown in 
Figure 2-4C.  The pathways appear to be a function of surface coverage (possibly due to 
microscopic difference in surface arrangement).  Although such examples of hysteresis are not 
commonly reported, Norde found similar behavior for albumin[81].  To schematically capture 
this incomplete refolding and pathway-dependent hysteresis behavior of AdhD, we believe that 
the single diagonal arrow in Figure 2-7 (Step V) can be replaced by multiple arrows representing 
different pathways.  In contrast to AdhD, we find two distinct desorbed populations for hAR: at 
high coverages, the desorption isotherms follow a single pathway to native-like structural 
refolding and the desorbed protein has no activity loss.  These results are unexpected due to the 
low thermal stability of hAR.  At low coverages, desorbed hAR maintains high levels of 
structural loss and ~80% activity loss, which more closely represents our hypothesis.  Unlike 
AdhD, no hysteresis is found.  This coverage-dependent desorption behavior can be represented 
in Figure 2-7 by a combination of arrows both at Step III (desorption to a perturbed state, the low 
coverage case) and at Step V (desorption to a native-like state, the high coverage case). 
Two driving forces are likely to govern the adsorption and structural unfolding of the proteins on 
the silica surface.  One driving force is enthalpic-based, due to charge differences between the 
protein and silica.  Although we have set the pH of the system to minimize overall point charge 
of the proteins, the surface charge profile of the two proteins vary, and localized charged patches 
can attribute to attractive/repulsive forces with the substrate.  3-D molecular models are shown in 
Figure S2-4 to illustrate the distribution of surface charge on both hAR and AdhD.  Based on 
these diagrams, qualitative assessment of the differences between the two proteins can be made.  
29 
 
While both proteins have a few localized patches (both positive and negative) this charge 
distribution is generally homogeneous across the surface of the protein for hAR.  By contrast, 
AdhD has more localized patches of both charges, with very few neutral areas. Specifically, 
positive patches seem to be more prevalent and larger for AdhD.  The implication of these 
differences in surface charge distribution is discussed below.  The other, entropic-based, driving 
force can be due to unfolding of secondary structure which increases conformational entropy of 
the protein molecule.  This has been cited in previous studies [9].  Both proteins demonstrate a 
helix-to-sheet transition, which indicates that once the protein comes into proximity of an 
interface, less favorable intermolecular interactions, which constrain the molecular dynamics of 
the protein, are lost in favor of a more relaxed conformation and more possible surface-
interactions. 
One possible explanation for the adsorption-induced denaturation of the thermophilic AdhD is 
the presence of the aforementioned positive patches on the surface of the protein, as seen in 
Figure S2-4.  Because the surface is negatively charged, strong Coulombic attraction would lead 
to high levels of surface affinity, with possibly concomitant structural unfolding as favorable 
attractive forces lead to new protein-surface bond formation. 
Unlike previous results that indicate the existence of only two states: a native-like desorbed and a 
highly perturbed adsorbed state [17], we see evidence of a non-native like desorbed state.  There 
is also indirect evidence that differentially unfolded states exist on the surface.  This hypothesis 
is supported as follows.  First, hAR desorbs in a coverage-dependent manner.  This may be a 
consequence of two (or more) adsorbed protein populations: at low coverages, proteins arriving 
early have longer residence times, allowing the occupation of more optimal attachment sites, 
formation of stronger surface bonds, and lateral inter-molecular interactions.  The detachment of 
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clusters would require greater free energy consumption, resulting in decreased desorbability [82].  
Conversely, at high coverages, a greater packing density may inhibit optimal protein-surface 
interactions [83].  Second, previous results show differences in elutability, bound fraction and 
interfacial area in adsorbed proteins, indicating that the existence of a single adsorbed population 
is unlikely [62, 84].  Finally, evidence for molten globule-like adsorbed states is postulated by 
studies involving carbonic anhydrase [85], lysozyme [86], and human growth hormone [87]. 
Our results indicate that overall adsorption behavior of these homologous proteins on silica does 
not correlate strongly with thermostability.  These results are surprising, as the structural stability 
of mutants has been previously hypothesized to strongly influence their surface affinity, degree 
of structural perturbation, and desorbability.  The main difference in our study is that we assess a 
greater difference in thermostability, by using proteins with naturally evolved structures that 
have been optimized for their environment.  As such, these homologs have similar topology and 
tertiary structure, but vastly different primary sequences.  In contrast, stability mutants have 
similar primary and tertiary structure, but often different topologies.  Both approaches introduce 
parameters into the system whose effect on adsorption behavior is unknown: for stability mutants, 
we hypothesize that altered topology may inhibit optimal protein/surface interaction, thus 
artificially reducing (or promoting) extent of surface-induced perturbation.  However, with 
naturally-occurring homologs, we cannot be certain that observed adsorption behavior is not due 
to differences in specific amino acid and surface interactions (due to the differences in primary 
structure).  We argue that although both systems have some limitations, the use of 
physiologically-relevant systems which allows a wider range of thermostabilities to be studied 
provides valuable insight which may have been previously overlooked. 
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We also find interesting differences in the desorption behaviour of hAR and AdhD. One 
explanation is that desorption is sensitive to structural stability because the same intermolecular 
forces which drive protein folding in solution will determine whether desorption is energetically 
more favourable.  However, we cannot be sure that the observed differences are not protein-
dependent.  In their natural environments, we know that these proteins are cystolic and may fold 
with the help of chaperones.  Furthermore, thermal stress causes irreversible unfolding in hAR 
while having no effect on AdhD.  Therefore, other intrinsic parameters, such as primary 
sequence may be the dominant factor in determining desorption behaviour.  
For more insight into the role of surface adsorption as a catalyst for protein destabilization, we 
compare the denaturing effects of the surface to other well–known stresses.  Figure S2-5 shows 
the far-UV CD spectra of hAR following thermal, chemical and surface-induced stress.  Thermal 
effects results in almost complete loss in secondary structure, while both surface- and 
chemically-induced stress cause only partial structural loss. Such differences are likely due to the 
probability of breaking the hydrogen bonds which maintain secondary structure in the presence 
of various disrupting forces [88].  Interestingly, thermal vs. surface-induced stress have a 
markedly different effect on AdhD: while extreme temperature excursions cause essentially no 
structural alteration, the surface is capable of irreversibly perturbing its structure.  
To the best of our knowledge, this study marks the first time that naturally occurring stability 
variants have been evaluated for interfacial behavior, by studying their differences and 
interdependencies along each step of the adsorption lifecycle.  Our results show that there is little 
correlation between a protein’s thermostability, surface affinity, and susceptibility to surface-
induced unfolding.  Additionally, we show interesting desorption behavior between the proteins 
and the importance of surface coverage in determining refolding pathway. Our results reveal that 
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role of thermostability in interfacial behavior may be less dominant than previously thought 
while protein surface properties may be a more important determinant of this behavior.  These 
conclusions shed some doubt on the notion that improving thermostability is the main way to 
reduce the effects of adsorption-induced changes of proteins. 
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2.7. Figures and Legends 
 
Figure 2-1 - Structural comparison between AdhD and hAR 
 
 
(A) Amino acid sequence alignment of AdhD and hAR showing < 30% sequence homology 
between the selected proteins; (B) 3-D homology model of AdhD (left) and crystal structure of 
hAR (PDB:2ACQ) (right) showing similarities in secondary and tertiary structure; (C) Far-UV 
CD spectra of native AdhD ( ) and native hAR  ( ) quantitatively demonstrating the 









Adsorption isotherms for AdhD, ○ (K=0.50 mg mL-1, Γmax = 1.68 mg m
-2) and hAR, ■ (K=0.35 
mg mL
-1, Γmax = 2.40 mg m
-2
) with least-squared fits to a Langmuir isotherm. Inset contains 
adsorption isotherms on logarithmic axes. Labels A-E indicate points selected for subsequent 
data sets. Error bars represent the standard deviation of three independent replicates. The inset 








Adsorbed protein spectra for AdhD (A) and hAR (B) as compared to the native spectra ( ) 
of each protein. Starting with the highest surface coverage, the line types indicate (Surface 
coverage and Ceq follow each line type):   (AdhD: 1.54 mg m
-2
, 2.44 mg mL
-1
; hAR: 1.98 mg 
m
-2
, 2.73 mg mL
-1
),  (AdhD: 1.51 mg m
-2
, 1.62 mg mL
-1
; hAR: 1.93 mg m
-2
, 1.66 mg mL
-
1
),  (AdhD: 1.08 mg m
-2
, 0.85 mg mL
-1
; hAR: 1.67 mg m
-2
, 0.83 mg mL
-1
),  
(AdhD: 0.78 mg m
-2
, 0.50 mg mL
-1
; hAR: 1.22 mg m
-2
, 0.24 mg mL
-1
), and  (AdhD: 0.51 
mg m
-2
, 0.24 mg mL
-1
; hAR: 0.84 mg m
-2
, 0.13 mg mL
-1
); (C) Fraction of secondary structure 
that exists as α-helical (circle) and -sheet (square) domains for AdhD (● and ■) and hAR (○ and 
□) for native protein and adsorbed protein.  
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Desorbed protein concentration as a function of rinse cycle for (A) AdhD and (B) hAR. Data 
shown for rinse cycles 2-10. Protein:particle ratios corresponding to five different regions along 
the adsorption isotherm (as labeled A-E in Figure 2-2) were used (surface coverage and Ceq 
follow each sample). AdhD: ● Sample A: 1.4 mg m-2, 1.9 mg mL-1; ■ Sample B: 1.2 mg m-2, 1.3 
mg mL
-1
;  Sample C: 0.82 mg m
-2
, 0.62 mg mL
-1
;   Sample D: 0.60 mg m
-2
, 0.25 mg mL
-1
;  
Sample E: 0.32 mg m
-2
, 0.09 mg mL
-1
; hAR: ● Sample A: 2.1 mg m-2, 3.2 mg mL-1; ■ Sample B: 
2.1 mg m
-2
, 2.0 mg mL
-1
;  Sample C: 1.8 mg m
-2
, 1.23 mg mL
-1





;  Sample E: 0.53 mg m
-2
, 0.04 mg mL
-1
. Each point is the average of three distinct 
replicates and error bars represent their standard deviation. Not shown on the graphs is the limit 
of detection of each assay, as all concentration values shown are above this limit. Desorption 
isotherms are shown in (C) AdhD and (D) hAR. Data for all 10 cycles are depicted, and symbols 
are consistent with those used in A and B. The solid line represents the Langmuir fit for the 
adsorption isotherm data and the dashed line represents a Langmuir fit for the desorption data. 








CD spectra of native protein (solid line) vs. desorbed protein (obtained from cycle 3 of the 
desorption experiments captured a surface coverages along the plateau value , transition 









Kinetic data showing percent native activity for desorbed AdhD (○) and hAR (■) at various 
levels of surface coverage. Desorbed protein has been taken from the third rinse cycle of the 
desorption experiments. Error bars represent standard deviations of three independent samples. 









Classical 4-state kinetic model, representing the native state in bulk before adsorption, the 
adsorbed state before unfolding, followed by structural rearrangement while on the surface, 






























 0.43 (118) 0.18 0.35 (112) 0.36 (119) 0.21 
Sheet 0.14 (39) 0.14 (39) 0.28 0.13 (48) 0.12 (40) 0.27 
Disordered 0.45 (125) 0.42 (115) 0.54 0.52 (154) 0.52 (169) 0.52 
 
* Where applicable, the number of amino acids assigned to each domain is indicated in 
parentheses 
a
Predictions based on 6 different algorithms averaged together (JPred, Porter, PsiPred, Prof, 
SCRATCH, 3DJigsaw) 
b
Homology model obtained as previously described [22] 
c
Deconvolutions of CD Spectra performed using CDPro Software 
d





2.8. Supplementary Information 
 
Further Experimental Details: 
Cloning. The following primers were used for the hAR cloning: The OE1_F primer was used 
with OE1_R to generate the first part of the gene, while OE2_F was used with the reverse primer 
OE2_R to generate the second part of the gene.  The pieces were denatured, annealed ,and 
extended to yield the full-length hAR gene. This strategy introduced an NcoI restriction site 
(underlined in OE1F) and a HindIII restriction site (underlined in OE2R).  








Protein Concentration. Standards for the BCA assays and protein samples for extinction 
coefficient measurements were made from purified lyophilized protein. 12 - 30 mL of purified 
protein were dialyzed against 2 L of 25 mM ammonium bicarbonate at 4
o
C with buffer 
replacement every 8-12 hours. The dialyzed protein samples were then lyophilized for 36 hours. 




Figure S2-1 - SWISS model output for AdhD and hAR 
 
Secondary structure predictions generated by the SWISS model program for AdhD (top) and 









Melting curve of AdhD (solid line) and hAR (dashed line) as obtained by following the CD 
spectra of both proteins at 222nm between 25 and 95
o
C. Samples were run in 1mm cuvettes. 
Buffer used is 10mM sodium cacodylate buffer at pH=5 (AdhD) and pH=6.9 (hAR). Only hAR 
exhibits unfolding behavior under these conditions, and the midpoint temperature of a sigmoidal 
fit (Tm = 57
o








Spectra used for determining adsorbed protein structure for AdhD (A) and hAR (B). Spectra 
shown: native ( ), resuspended adsorbed protein-particle pellet ( ), supernatant from 
resuspended pellet ( ), adsorbed protein ( ), error in adsorbed spectrum ( ). 









Cartoon diagrams for (A) AdhD and (B) hAR showing the similarities in secondary structure and 
surface representations of surface charge for (C) AdhD and (D) hAR and surface hydrophobicity 








Far-UV CD spectra of haR in the native state (solid), following chemical denaturation by 6M 
GdHCl ( ), surface-induced denaturation, i.e. desorbed protein ( ) and following 
thermal denaturation upon heating to 95
○











Helix fraction Sheet fraction Random fraction 
Native 0.20 0.27 0.51 
1.98 0.05 0.33 0.49 
1.93 0.08 0.36 0.47 
1.67 0.05 0.34 0.50 
1.22 0.06 0.37 0.52 







Helix Sheet Random 
Native 0.18 0.28 0.50 
1.54 0.07 0.34 0.53 
1.51 0.06 0.35 0.51 
1.08 0.09 0.35 0.49 
0.78 0.08 0.34 0.52 
0.51 0.09 0.35 0.52 
 
Fraction of secondary structures of adsorbed protein spectra upon deconvolution of CD data for 




Table S2-3 - Specific activities of desorbed AdhD and hAR 
 
 Specific Activity (min
-1
) 






Native 63 85 
Point A 37 (1.30) 83 (2.10) 
Point B 34 (1.13) 75 (2.14) 
Point C 35 (0.87) 89 (1.82) 
Point D 34 (0.59) 90 (1.46) 
Point E 43 (0.39) 24 (0.53) 
Point F 34 (0.19) 26 (0.08) 
 
Specific activity values for AdhD (left column) and hAR (right column) of native protein and 
desorbed protein at various coverages.  Surface coverage in mg m
-2
 is given in parentheses for 
each point.  Values from literature for both 
a
AdhD [68] and 
b







3. Immobilization via Periplasmic Expression for Whole-cell 
Biocatalysis 
3.1.  Characterization of Carbonic Anhydrase-bearing Biocatalysts 
Note: A version of this chapter entitled “Periplasmic expression of carbonic anhydrase in Escherichia coli: a new biocatalyst for CO2 hydration.” 
is published in Biotechnology and Bioengineering (2013), volume 110, issue 7, pages 1865-1873,  with co-authors Alissa Ah-Hyung Park and 
Scott Banta.  
 
TNP designed and performed all experiments, analyzed the data, and wrote the manuscript. 
3.1.1. Abstract 
Carbonic anhydrase is a valuable and efficient catalyst for CO2 hydration.  Most often the free 
enzyme is employed which complicates catalyst recycling, and can increase cost due to the need 
for protein purification. Immobilization of the enzyme may address these shortcomings.  Here 
we report the development of whole-cell biocatalysts for CO2 hydration via periplasmic 
expression of two forms of carbonic anhydrase in Escherichia coli using two different targeting 
sequences.  The enzymatic turnover numbers (kcat) and catalytic efficiencies (kcat/KM) were 
decreased by an order of magnitude as compared to the free soluble enzyme, indicating the 
introduction of transport limitations.  However, the thermal stabilities were improved for most 
configurations (>88% activity retention up to 95
o
C for 3 of 4 whole-cell biocatalysts), 
operational stabilities were more than satisfactory (100% retention after 24 hours of use for all 4 
whole-cell biocatalysts), and CO2 hydration was significantly enhanced relative to the 
uncatalyzed reaction (~50-70% increase in CaCO3 precipitate formed).   A significant advantage 
of the whole-cell approach is that protein purification is no longer necessary, and the cells can be 
easily separated and recycled in future applications including biofuel production, biosensors, and 




Carbonic anhydrases (CA; EC 4.2.1.1) are well-studied Zn-binding metalloenzymes that are 
nearly ubiquitous in nature [39, 42].  Among the fastest known enzymes, their primary catalytic 





) ions, as shown below [93]: 
                (1) 
            
     (2) 
    
       
      (3) 
For most organisms, these reactions are important in complex processes such as respiration and 
photosynthesis [94].  However, the uncatalyzed reaction rate of this conversion is slow and the 
amount of bicarbonate ions formed is not enough to match the needs of the organism.  Also, the 
accumulation of CO2 within the organism  is detrimental to its health [95].  Fortunately, carbonic 







via the pathway shown below [41]: 
              
     (4) 
                    
  (5) 
       
                    
 
 (6) 
    
       
      (3) 
These enzymes have been organized into 3 main classes: , , and   [96].  The -class is 
comprised of all CAs found in mammals, including the 10 human isoforms that have been 
identified.  The -class, also called “plant-type carbonic anhydrases”, consists of enzymes 
isolated and identified mainly from plants, but also from several bacterial and archaeal species.  
And, the -class, thought to be evolutionarily the oldest, is fairly unstudied since only one form 
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has been isolated and purified [97]. Additionally, δ- [98], ε- [99], and ζ-classes [100] have also 
been identified, but remain poorly studied as yet. 
Previous work on CA has focused on the catalytic mechanism of the enzymes [39, 41, 101-106].  
Other  research pertains to the activators and inhibitors of CA [107-109] and the potential use of 
CAs as therapeutics [110, 111].  Within the last decade, researchers have been interested in 
carbon capture mediated by CA [47, 112-114].  Other industrial applications for the enzymes 
include any process in which CO2 hydration or fixation rates need to be increased, such as 
engineering photosynthesis [48], biofuel production [49], and electrochemical biosensors [50]. 
In this study, a -class (Cab from Methanobacterium thermoautotrophicum; PDB: 1G5C) and a 
-class (Cam from Methanosarcina thermophile; PDB: 1THJ) CA were separately expressed in 
the periplasm of Escherichia coli for use as whole-cell biocatalysts for carbon dioxide hydration.  
The crystal structure of Cab was resolved in 2001 and showed that Cab naturally dimerizes.  
Each monomer consists of a parallel -sheet core surrounded by -helices [115].  The structure 
and stability of Cab were characterized previously and the enzyme was found to be the most 
stable form of carbonic anhydrase ever isolated, but also among the slowest with turnover rates 




 [42, 44].  The crystal structure of Cam was also determined previously 
and showed that the enzyme forms homotrimers which oligomerize into hexamers.  The 
monomeric structure consists of a left-handed -helix, a structure unlike any other identified 
form of carbonic anhydrase [42, 116].  Cam has also been previously characterized and also 
showed low activity relative to other carbonic anhydrases.  It is natively expressed in the 
periplasm of the archaeabacteria from which it is derived [46, 51, 117].  This familiarity with the 
periplasmic space is beneficial since the likelihood of inactivation or inhibition due to the 
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oxidative environment found in the periplasm is reduced.  The crystal structures of both enzymes 
can be seen in Figure 3-1. 
The goal of this research was to characterize whole-cell biocatalysts containing periplasmically 
expressed CA.  We hypothesized that the outer cell membrane of E. coli would present a 
transport barrier for the flux of reactant and product across the outer membrane.  This would 
reduce the overall reaction rate, but should not affect the catalytic activity of the enzymes.  Based 
on prior research [6], we also presumed that this immobilization technique would result in 
stabilization of the catalysts.  Lastly, we compared the performance of the whole cell catalysts in 
a potential carbon capture and storage application. 
3.1.3. Materials and Methods 
Materials.  Oligonucelotides were obtained from Integrated DNA Technologies (Coralville, IA).  
Restriction enzymes and T4 DNA Ligase were from New England Biolabs (Ipswich, MA).  All 
other chemicals were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise indicated. 
Cloning.  The genes for Cab and Cam were synthesized and subcloned into the pBSK 
(BlueScriptII) cloning vector by Epoch Life Science (Sugarland, TX).  The nucleotide and amino 
acid sequences for the two proteins can be seen in Figure S3-1.  The genes were then amplified 
from this plasmid using oligonucleotides TP05/TP09, and TP03/TP10 for Cab and Cam, 
respectively.  The amplified inserts were digested using restriction enzymes NdeI/HindIII.  The 
inserts were then ligated into similarly digested pET-24a expression vector (Novagen, 
Gibbstown, NJ) using T4 DNA Ligase.  This vector attaches a 6xHis tag to the C-terminus of the 
desired protein.  The constructs were electroporated into BLR(DE3) E. coli cells (Novagen) and 
selected on agar plates containing 50 g/mL kanamycin.  A similar procedure was used to clone 
Cab and Cam into the pBAD/gIIIA periplasmic expression vector (Invitrogen, Grand Island, NY) 
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using primers TP11/TP12 and TP42/TP14 respectively and restriction enzymes KpnI/HindIII for 
Cab and SacI/KpnI for Cam.  This vector fuses the gIII periplasmic leader peptide to the N-
terminus of the desired protein and a myc epitope and 6xHis tag to the C-terminus.  These 
constructs were also electroporated into BLR(DE3) cells and selected on agar plates containing 
50 g/mL ampicillin.  As an alternative periplasmic expression system, Cab and Cam were 
cloned into the pAK100 vector, which fuses the pelB periplasmic leader peptide to the N-
terminus of the desired protein and a myc epitope to the C-terminus.  This was accomplished 
using primers TP34/TP35 and TP36/TP37 respectively and the restriction enzyme SfiI.  These 
constructs were electroporated into BLR(DE3) cells and selected on agar plates containing 35 
g/mL chloramphenicol.  Due to poor expression levels from this vector, the fusions were then 
cloned into the pET-24a vector using primers TP38/TP39 and TP40/TP41 respectively with 
restriction enzymes NdeI/HindIII.  All primer sequences can be found in Table S3-1. 
Protein Expression and Purification.  Proteins were expressed at 37
o
C in 1 L of Terrific Broth 
(TB) supplemented with 1 mM ZnCl2 and the appropriate antibiotic (Amp or Kan).  All cultures 
were inoculated with 5 mL overnight cultures.  Expression was induced at OD600=0.6 by adding 
0.02% L-arabinose (pBAD) or 200 M IPTG (pET).  After 4 hours of expression, the cells were 
pelleted via centrifugation at 3,000xg for 10 minutes.  The cells were resuspended in 100 mL of 
20 mM Tris-HCl, 150 mM NaCl, and 40 mM imidazole at pH 7.4.  Some cultures were stored at 
4
o
C for use as whole-cell biocatalysts.  For purification, the resuspended cells were lysed by 
sonication for a total of 8 minutes.  The lysate was clarified via centrifugation at 15,000xg for 30 
minutes.  The carbonic anhydrase was purified from the lysate using a HisTrap (GE Healthcare) 
column on a fast performance liquid chromatography (FPLC) system (GE).  The protein was 
loaded and washed at 5 mL/min in binding buffer (20 mM Tris-HCl, 150 mM NaCl, 40 mM 
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imidazole, pH 7.4).  Elution was achieved with a linear gradient of elution buffer (20 mM Tris-
HCl, 150 mM NaCl, 500 mM imidazole, pH 7.4) over 20 column volumes.  Fractions containing 
the protein were then pooled together and concentrated using an Amicon 10 kDa molecular 
weight cutoff (MWCO) centrifugal filter (Millipore, Billerica, MA).  Protein concentrations were 









 for Cab and Cam, respectively.  These values represent the average between 
coefficients calculated based on the amino acid sequence as described previously [118] and using 
the ProtParam tool developed by the Swiss Institute of Bioinformatics (Lausanne, Switzerland). 
Osmotic Shock Treatment.  The periplasmic and cytosolic fractions of the whole-cell biocatalysts 
were separated using an osmotic shock protocol provided by Invitrogen.  Briefly, cell pellets 
from just before induction (t=0 hours) and after expression (t=4 hours) were resuspended in 
Buffer OS1 (20 mM Tris-HCl, 2.5 mM EDTA, 20% sucrose, pH 8.0) to an OD600 of 5.0.  The 
suspensions were incubated on ice for 10 minutes and then centrifuged for 1 minute at 13,000 
rpm.  The supernatant was decanted and the pellets were resuspended in Buffer OS2 (20 mM 
Tris-HCl, 2.5 mM EDTA, pH 8.0) to an OD600 of 5.0.  After 10 minutes on ice, the suspensions 
were centrifuged for 10 minutes at 13,000 rpm.  The supernatant contained the periplasmic 
fraction and was transferred to a fresh tube.  The remaining pellet represented the cytosolic 
fraction. 
Quantitative Western Blot Analysis.  Protein samples were separated electrophoretically by size 
on a 4-12% Bis-Tris polyacrylamide gel.  The proteins were transferred to a nitrocellulose 
membrane using a semi-dry blotting unit (Thermo Fisher Scientific, Waltham, MA).  The 
transfer was performed using Towbin Buffer (25 mM Tris-HCl, 192 mM glycine, and 20% 
methanol).  The blotted membrane was then transferred to a 50 mL centrifuge tube with the 
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blotted surface facing inwards.  Blocking was performed using 1x phosphate buffered saline 
(PBS) containing 0.05% Tween-20 and 5% nonfat dry milk for 2 hours at room temperature (RT).  
The blocking solution was decanted and replaced with a primary antibody solution (PBS, 0.05% 
Tween-20, 2.5% nonfat dry milk, and 800 ng/mL anti-c-myc-FITC conjugated monoclonal 
antibody).  The membrane was incubated in this solution for 16 hours at 4
o
C and then rinsed 3 
times for 10 minutes each at RT in PBS containing 0.05% Tween-20.  Visualization was 
performed on a MAESTRO2 In Vivo Imaging System (CRI, Woburn, MA) using a 520 nm filter 
and a 200 msec exposure time.  To quantify the visible bands, the intensity of each band was 
determined using the ImageJ software package (National Institute of Health; NIH, Bethesda, 
MD). 
Carbonic Anhydrase Activity.  The carbon dioxide hydration rates were determined by stopped-
flow spectroscopy at 25
o
C using a modified version of the changing pH indicator method [101], 
similar to an assay described previously [45].  A BioLogic stopped-flow apparatus (BioLogic, 
Claix, Isère, France) was used with a Jasco J-815 CD Spectrometer (JASCO, Easton, MD).  
Solutions of saturated CO2 were prepared by bubbling compressed CO2 into deionized water 
containing 55.6 M m-cresol purple at 25oC until it reached a pH of 3.91.  The concentration of 
carbon dioxide was varied from 3 to 28 mM by mixing with N2-saturated water with a similar 
concentration of m-cresol purple.  Catalyst solutions were prepared in 100 mM Tris at pH 9.0.  
The absorbance at 578 nm was followed for the final solution consisting of 10 mM Tris with 50 
M m-cresol purple.  Kinetic parameters (corrected for the uncatalyzed reaction) were 
determined by fitting the steady-state portion  of each measurement to the differential form of the 
Michaelis-Menten equation using Berkeley Madonna software [119]. 
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Biocatalyst Stability.  Purified enzyme solutions and whole-cell biocatalyst suspensions in 100 
mM Tris at pH 9.0 were incubated at temperatures varying from 25 to 95
o
C for 15 minutes.  
After heating, the solutions were cooled on ice for 5 minutes.  The activity of each solution was 
then measured using the stopped-flow method described above.  The whole-cell biocatalysts 
were also tested for activity retention over a period of 24 hours.  CO2 was bubbled into cell 
suspensions in deionized water for 24 hours.  Every 2 hours, the cells were pelleted and 
resuspended in fresh water to remove the accumulated bicarbonate and carbonate ions.  Every 6 
hours, a sample was removed and the cells were pelleted via centrifugation at 13,000 rpm for 1 
minute.  The supernatant was decanted and the pellets were resuspended in 100 mM Tris at pH 
9.0.  The activity and OD600 at each time point were measured to determine the CO2 hydration 
rates of the whole-cells after extended use. 
Precipitation.  A catalyst solution containing either whole-cell biocatalysts or an equivalent 
amount of purified enzyme was added to a 15 mL centrifuge tube.  Using a glass gas dispersion 
tube (Ace Glass, Vineland, NJ), compressed CO2 gas was bubbled into each solution for 30 
seconds at approximately 1 psi.  This amount of time was determined to be optimal by measuring 
the pH curves of the various catalysts (Figure S3-2).  After bubbling, calcium chloride (CaCl2) 
and calcium carbonate (CaCO3) were added to the solution to initiate the formation and 
precipitation of CaCO3.  CaCl2 served as a Ca
+2
 ion source and the CaCO3 served as seed 
particles for nucleation.  The solutions were then allowed to sit at RT for 1 hour.  Precipitate was 
collected and dried using spin columns (Epoch Life Science, Sugarland, TX) on a vacuum 
manifold (Qiagen, Valencia, CA).  Each column was centrifuged at 5,000xg for 2 minutes to 
remove any residual water and weighed to determine the total mass.  The masses of the empty 
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column, cells added, and CaCO3 added were subtracted to determine the amount of CaCO3 
formed.   
Statistical Analysis.  Analysis of variance was performed using the General Linear Model on the 
precipitation data using the Minitab program (Minitab Inc., State College, PA).  Post hoc 
analysis was done using the Tukey Method with a 95% confidence level. 
3.1.4. Results 
Plasmid Constructs.  Both CA isoforms were successfully cloned into the pET-24a vector 
resulting in constructs pET-Cab and pET-Cam.  After transformation, two colonies from each 
were selected for verification through DNA sequencing (GENEWIZ, South Plainfield, NJ) and 
creation of glycerol stocks.    Also, two periplasmic leader peptides were successfully fused to 
Cab and Cam in the pBAD/gIIIA and pET-24a vectors.  The resultant constructs (pBAD-gCab, 
pBAD-gCam, pET-pCab, and pET-pCam) were transformed and two colonies of each were 
selected for verification and creation of glycerol stocks.  Whole-cell biocatalysts made using 
these constructs will be called BLR-gCab, BLR-gCam, BLR-pCab, and BLR-pCam. 
Quantitative Western Blot Analysis.  Western blot analysis was performed on samples obtained 
following osmotic shock.  This was done to locate the enzyme within the cell and determine the 
amount of enzyme expressed per cell.  Locating the protein was a qualitative observation made 
by comparing the intensity of visible bands in different lanes of the nitrocellulose membrane.  
For example, Figure 3-2 shows that for BLR-gCab, after 4 hours of expression a clear band is 
visible Lane 2 (periplasmic fraction) while nothing is visible in Lane 3 (cytoplasmic fraction) for 
the same timepoint.  This suggests that a large fraction of the recombinantly expressed carbonic 
anhydrase exists in the periplasm.  Any CA located in the cytosol was below the limit of 
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detection.  Similar results were seen for BLR-gCam, BLR-pCab, and BLR-pCam (data not 
shown). 
The amount of enzyme expressed per cell was calculated using a standard curve.  Calmodulin 
was expressed using a control plasmid provided with the pBAD kit.  Once it was purified and 
lyophilized, the protein was weighed to obtain a stock solution of known concentration.  
Dilutions of this stock were blotted using the protocol above (data not shown) and the 
concentration was plotted against band intensity and used to calculate the concentrations of gCab 
(352±17 fg/cell), gCam (50±3 fg/cell), pCab (661±26 fg/cell), and pCam (559±47 fg/cell) 
expressed in the periplasm. 
Whole-cell Kinetics.  Kinetic parameters for Cab and Cam purified from all three vectors can be 
found in Table 3-1 and Table 3-2, respectively.  Whole-cell kinetic parameters are also presented 
on a per-cell basis.  Purified enzyme kinetics were corrected for the uncatalyzed reaction rate 
while whole-cell kinetics were corrected for the reaction rates of BLR cells not expressing 
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On a per cell basis, the kinetics of whole-cell biocatalysts generated using the pelB leader 
sequence have higher rates, and better efficiencies (reported as Vmax/cell/KM).  This could be due 
to the higher expression levels seen with pelB, or perturbations in the outer membrane reducing 
the overall diffusion limitation of this system.  A comparison of the whole-cell kinetics and 
purified enzyme can be seen in Figure 3-3.  This figure was obtained using the measured kinetic 
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parameters, a fixed number of cells, and the equivalent concentration of purified enzyme based 
on the expression data above.  This figure shows that the loss in reaction rate is approximately 
one order of magnitude.  This loss in activity from the purified enzyme to the whole-cells 
indicates that the reaction is likely limited by the diffusion of reactant and/or product across the 
outer cell membrane of E. coli.   
Biocatalyst Stability.  As mentioned above, protein immobilization often serves as a method by 
which a protein or enzyme can be stabilized.  The term “stability” is a broad term and can be 
divided into several different forms of stability.  In this study, the thermal and operational 
stabilities were selected for measurement. 
Thermal stability data is shown in Figure 3-4.  Following incubation at 95
o
C, gCab and pCab lost 
15±3% and 13±3% of their original activities, respectively, while gCam and pCam lost 30±1% 
and 19±1%, respectively.  Conversely, BLR-gCab and BLR-pCab only lost 3±1% and 1±2% of 
their original activities, respectively, and BLR-gCam only lost 12±3%.  In these three cases, 
immobilization of the whole-cells stabilized the enzymes at high temperatures.  However, BLR-
pCam lost 35±2% of its original activity, the only case in which periplasmic expression did not 
improve the thermal stability of the enzyme.   
After 24 hours of continuous use, the whole-cell biocatalysts also showed a high level of 
operational stability.  The results of these experiments can be seen in Figure S3-3.  On a per-cell 
basis, BLR-gCab, BLR-pCab, BLR-gCam, and BLR-pCam retained 106±3%, 109±1%, 95±2%, 




Precipitation.  To investigate the carbon capture capabilities of the biocatalysts as a potential 
application, precipitation experiments were performed.  Figure 3-5 shows the results for purified 
enzymes, whole-cell biocatalysts, and osmotically shocked whole-cell biocatalysts using the gIII 
peptide (Panel A) and the pelB peptide (Panel B).  As controls, the uncatalyzed rate, untreated 
BLR cells expressing no recombinant CA, and osmotically shocked BLR cells expressing no 
recombinant CA were used.  Since the experiments for each leader peptide were performed at 
different times, the controls were tested each time to insure the accuracy of the results. 
For both sets of data, the controls within a given experiment all generated similar masses of 
CaCO3.  For the experiment using gIII, the amount precipitated was 0.07-0.08 g while for pelB 
about 0.09-0.1 g precipitated.  This indicates that the host cells had very little effect on the 
amounts precipitated.  Unsurprisingly, the purified enzymes for both cases precipitated the 
greatest masses at 0.14 g, 0.19 g, 0.17 g, and 0.24 g for gCab, gCam, pCab, and pCam, 
respectively.  For the whole-cell biocatalysts, these masses decreased to 0.12 g, 0.11 g, 0.13 g, 
and 0.14 g for BLR-gCab, BLR-gCam, BLR-pCab, and BLR-pCam, respectively.  Despite these 
reductions, the whole-cell values are greater than the controls.  Degradation of the outer 
membrane through osmotic shock caused CaCO3 to precipitate at higher levels than the whole-
cell scenarios (0.14 g for BLR-gCab, 0.13 g for BLR-gCam, 0.13 g for BLR-pCab, and 0.14 g 
for BLR-pCam).   
ANOVA was performed on the data using the General Linear Model to determine which factors 
had the greatest impact on the differences in CaCO3 precipitated.  Based on the F distributions 
for the three factors considered, namely the enzyme type, cell type, and the interaction between 
the two, p-values for these factors were all less than 0.001.  These values indicate that it is 
extremely unlikely the observed results are due to chance.  Post hoc analysis using the Tukey 
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method with a 95% confidence interval showed that there is a significant difference between the 
results obtained with CA and those obtained without CA.  Also, there is a significant difference 
between using free enzyme and using whole-cell biocatalysts.  However, osmotically shocked 
cells were not significantly different from whole-cells. 
3.1.5. Discussion 
Protein immobilization is a technique by which a protein of interest is attached to or entrapped in 
a solid support.  By doing so, the stability of the enzyme can be improved [6].  As an added 
benefit, the physical size of the catalyst increases, simplifying separation of the catalyst from the 
reaction solution for recycling since separation of dissolved enzyme requires expensive and time-
consuming unit operations.  Immobilization of carbonic anhydrase has been studied in terms of 
adsorption to various solid surfaces [120], attachment of CA-enriched organisms to chitosan 
beads [121], immobilization via covalent coupling [122], and recently cell surface display 
through ice nucleating proteins [30].  However, periplasmic expression of CA in E. coli for use 
as a whole-cell biocatalyst has not yet been studied. 
The use of E. coli as whole-cell biocatalysts has been previously studied [28], as has periplasmic 
expression of proteins [29].  In these studies, outer membrane permeability was documented as a 
potential limitation, and reduction in activity up to 2 orders of magnitude has been reported for 
whole-cell biocatalysts as opposed to free enzyme [38].  Despite these issues, the concomitant 
increase in stability obtained via immobilization and the elimination of protein purification may 
balance the activity losses, enhancing the suitability of these catalysts. 
Cab and Cam were expressed in the periplasm of E. coli using the gIII and pelB signaling 
peptides fused to their N-termini.  Relative to purified enzymes, the reaction rates of the whole-
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cell biocatalysts decreased by between 1 and 2 orders of magnitude based on equivalent masses 
of enzyme, as expected [38].  This indicated that the overall CO2 hydration reaction is likely 
diffusion-limited in the whole cells.  This was expected due to the introduction of the outer 
membrane as a transport barrier. 
Often, catalyst stability is measured in terms of long-term storage or shelf life [120].  In our 
experiments, we measured two forms of stability to determine the resistance of our catalysts to 
damage from both factors.  Our results showed an improvement in thermal stability of the protein 
and retention of whole-cell activity after extended use, both of which are important for process 
integration [123].  Three of the four whole-cell biocatalysts exhibited more than 88% of their 
original activity after exposure to temperatures up to 95
o
C.  The fourth, BLR-pCam, lost 35% of 
its original activity, but also showed the best kinetics.  It is possible that this effect is due to outer 
membrane perturbations that occur when using the pelB leader peptide with Cam.  These results 
also imply that the activity and thermal stability of the whole-cell biocatalysts are linked and 
there is an apparent tradeoff between the activity and thermal stability of the catalysts that must 
be considered for use in a process. 
All four whole-cell biocatalysts retained 100% of their original activity after 24 hours of use.  
We believe this stabilization of the enzymes in the cells is due to crowding in the periplasm.  
This would cause the entropic cost of protein unfolding within the periplasm to become 
unfavorable.  Thus, a larger fraction of the immobilized proteins would remain folded at higher 
temperatures and for longer periods of time. 
This crowding effect increases the attractiveness of periplasmic expression as a means of 
immobilization over other, more common immobilization techniques, such as adsorption to a 
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solid surface.  Physisorption has been studied previously [16, 124] and was shown to cause 
proteins to lose structure when immobilized.  In fact, as the available surface area to a protein 
molecule increases, so does the degree to which the protein unfolds [11].  Even very 
thermostable proteins experience this denaturation on the surface [125]. 
Finally, we demonstrated the use of whole-cell biocatalysts in carbon mineralization [126, 127], 
a potential carbon capture and storage application.  While purified enzymes performed the best 
in these carbonate precipitation experiments, the additional cost of protein purification may limit 
the value of this approach.  Statistical analysis of this data showed a significant improvement in 
the use of the whole-cell biocatalysts compared to the uncatalyzed reaction.  However, 
significant improvement was not seen when using osmotically shocked cells, which should 
liberate the enzyme.  This is most likely due to incomplete fracturing of the outer membrane of 
all cells, causing the diffusion barrier to persist.  A more comprehensive economic analysis will 
be needed to truly gauge the benefit of using the whole cells. 
Future directions should focus around improvement of the overall hydration reaction of the 
whole cells.  This could potentially be accomplished by modifying the cell membrane to enhance 
permeability, artificially permeabilizing the outer membrane using various chemical agents, or 
by using different microorganisms as carriers. 
3.1.6. Conclusions 
By immobilizing Cab and Cam within the periplasm of E. coli cells, we have created new whole-
cell biocatalysts for CO2 hydration.  While this introduces a transport barrier that reduces the 
activity as compared to the soluble enzymes, the whole cell approach increased thermal stability 
and should reduce catalyst costs.  The cells were used to demonstrate carbon dioxide hydration 
64 
 
for a capture and mineralization application, and these catalysts may be valuable for other carbon 
capture scenarios. 
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3.1.8. Figures and Tables 
 




Crystal structures for the Cab (-type; M. thermoautotriphicum; MW: 19.6 kDa; PDB:1G5C) (A) 
monomer and (B) dimer, and the Cam (γ-type; M. thermophila; MW: 23.0 kDa; PDB:1THJ) (C) 
monomer and (D) trimer.  In the oligomer structures, each color represents one monomer, and 








Nitrocellulose membrane showing BLR-gCab cellular fractions.  Lanes 1-3 represent the 
molecular weight standard, periplasmic fraction after 4 hours of expression, and cytosolic 
fraction after 4 hours of expression.  Membranes were labeled using an anti-myc-c-FITC 
conjugated antibody and visualized on a MAESTRO2 in vivo Imaging System.  Similar results 









Comparison between purified enzyme (  ) and whole-cell biocatalysts ( ) using pCab.  
5x10
7










Thermal stability data for Cab and Cam expressed using the (A) gIII and (B) pelB leader 
peptides plotted as percent of original activity.  For panel A, stabilities are reported for gCab ( ), 
gCam ( ), BLR-gCab ( ), and BLR-gCam ( ).  Similarly for panel B, stabilities are reported 
for pCab ( ), pCam ( ), BLR-pCab ( ), and BLR-pCam ( ).  Errors bars represent the standard 








Masses of CaCO3 precipitate formed in the absence of recombinantly expressed enzyme (control 
experiments), Cab, and Cam using the (A) gIII and (B) pelB leader peptides.  For each catalyst, 3 
configurations were tested: (x) free enzyme, (y) whole-cell biocatalysts, and (z) osmotically 
































 1.7 x 10
4
 2.9 5.9 x 10
3
 - - 
Cab 1.6 ± 0.1 x 10
4
 3.0 ± 0.2 5.3 ± 0.3 x 10
3
 - - 
gCab 2.0 ± 0.1 x 10
4
 3.0 ± 0.1 6.5 ± 0.1 x 10
3
 - - 
BLR-gCab - 38 ± 5 - 2.5 ± 0.6 x 10
-7
 6.5 ± 0.7 x 10
-9
 
pCab 1.8 ± 0.1 x 10
4
 2.9 ± 0.1 6.5 ± 0.2 x 10
3
 - - 
BLR-pCab - 39 ± 4 - 3.4 ± 0.4 x 10
-7





Previously published values [45] 
“-“ indicates parameter is not relevant to catalyst 















































 7.7 x 10
4
 15 5.2 x 10
3
 - - 
Cam 6.1 ± 3.0 x 10
4
 16 ± 1 3.7 ± 1.7 x 10
3
 - - 
gCam 6.8 ± 1.5 x 10
4
 17 ± 1 4.0 ± 1.0 x 10
3
 - - 
BLR-
gCam 
- 31 ± 3 - 1.9 ± 0.4 x 10
-7
 6.0 ± 0.6 x 10
-9
 
pCam 7.7 ± 1.5 x 10
4
 14 ± 1 5.7 ± 1.4 x 10
3
 - - 
BLR-
pCam 
- 31 ± 3 - 5.9 ± 0.9 x 10
-7





Previously published values [45] 
“-“ indicates parameter is not relevant to catalyst 
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Table S3-1 - Primer sequences used for Cab and Cam cloning 
Primer Description Sequence 
TP03 Cam Forward NdeI AGT CAG CAT ATG CAG GAA ATA ACC GTG GAT 
TP05 Cab Forward NdeI AGT CAG CAT ATG AGG TTT GTT AGC ATG ATT ATT 
TP09 Cab Reverse HindIII 
AGT CAG AAG CTT TTT ATC TTC ATC AAG GTA AAG 
TGG 
TP10 Cam Reverse HindIII 
AGT CAG AAG CTT TTT TGA AGT TTC TTT ATA ACC 
CTC 
TP11 Cab Forward KpnI 
AGT CAG GGT ACC ATA TGA GGT TTG TTA GCA TGA 
TT 
TP12 Cab Reverse HindIII 
AGT CAG AAG CTT CCT TTA TCT TCA TCA AGG TAA 
AGT GG 
TP14 Cam Reverse KpnI 
AGT CAG GGT ACC CTT TTG AAG TTT CTT TAT AAC 
CCT C 
TP42 Cam Forward SacI AGT GAC TAG AGC TCA TGC AGG AAA TAA CCG 
TP34 Cab Forward SfiI 
AGT CAG GGC CCA GCC GGC CAT GGC GAG GTT TGT 
TAG CAT GAT TAT TAA A 
TP35 Cab Reverse SfiI 
AGT CAG GGC CCC CGA GGC CCC GCC ATC TTC ATC 
AAG GTA AAG TG 
TP36 Cam Forward SfiI 
AGT CAG GGC CCA GCC GGC CAT GGC GCA GGA AAT 
AAC CGT GGA T 
TP37 Cam Reverse SfiI 
AGT CAG GGC CCC CGA GGC CCC GCC TGA AGT TTC 
TTT ATA ACC CT 
TP38 pelB-Cab Forward NdeI AGT CAG CAT ATG AAA TAC CTA TTG CCT ACG 
TP39 pelB-Cab Reverse HindIII AGT CAG AAG CTT CAG GTC TTC CTC AGA GAT 




AGT CAG AAG CTT CAG GTC TTC CTC AGA GAT 
 





Figure S3-2 - pH curves for free and immobilized enzymes 
 
pH curves for Cab and Cam as purified enzymes and whole-cell biocatalysts using the (A) gIII 
and (B) pelB leader peptides.  Panel A contains curves for the uncatalyzed reaction ( ), BLR 
cells expressing no recombinant CA ( ), gCab ( ), gCam ( ), BLR-gCab ( ), and BLR-gCam 
( ).  Similarly, panel B contains curves for the uncatalyzed reaction ( ), BLR cells expressing 
no recombinant CA ( ), pCab ( ), pCam ( ), BLR-pCab ( ), and BLR-pCam ( ).  Error bars 





Figure S3-3 - Activity retention after 24 hours 
 
Retention of activity by BLR-gCab ( ), BLR-gCam ( ), BLR-pCab( ), and BLR-pCam ( ) 
after 24 hours of catalysis plotted as a percentage of their initial whole-cell biocatalyst activities. 






3.2. Operational Stability Measurements 
 
Note: A version of this chapter entitled “An Automated Method for Measuring the Operational Stability of Biocatalysts with Carbonic Anhydrase 
Activity.” is published in Biochemical Engineering Journal (2014), volume 82, pages 48-52,  with co-authors Edward J Swanson, Alissa Ah-
Hyung Park, and Scott Banta.  
 
TNP designed and performed all experiments, analyzed the data, and wrote the manuscript. 
3.2.1. Abstract 
The operational stability of an enzyme can be quantified by its half-life, or the length of time 
after which 50% of its original activity has degraded.  Ideally, continuous methods for measuring 
half-lives are preferred but they can be expensive and relatively low throughput.  Batch methods, 
while simple, cannot be used for all enzymes.  For example, batch reactions can be difficult 
when there is a gas phase reactant or when there is significant product or substrate inhibition.  
Here we describe a repeated-batch method for measuring the half-life of carbonic anhydrase 
(CA)-based biocatalysts by automated periodic switching between a forward and reverse reaction.  
This method is inexpensive and can be multiplexed for high-throughput analysis of enzyme 
variants.  Several purified CA enzymes as well as whole-cell biocatalysts with engineered CA 
activity were evaluated with this method.  The results indicate a significant increase in 
operational stability is achieved upon immobilization of CA in the cellular periplasm of E. coli. 
3.2.2. Introduction 
The stability of an enzyme or biocatalyst is a critical parameter.  It can dictate the proper storage, 
optimal reaction conditions, and functional lifetime of a biocatalyst.  However, the term 
“stability” covers a broad range of properties including thermal stability, pH stability, and 
operational (or kinetic) stability [123, 128-131].  The stability of an enzyme is dependent on 
several phenomena including the structure of the protein, hydrophobic interactions, ionic 
interactions, hydrogen bonding, and other weak interactions [132-135].  Previously, researchers 
have explored methods to stabilize enzymes via directed evolution [136], rational mutagenesis of 
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surface residues [137, 138], the introduction of non-native disulfide bonds [139], and various 
immobilization techniques [6].  In most of these studies, the thermal stability of the enzymes is 
being measured and is assumed to be related to the overall stability of the catalyst, including the 
operational stability.  However, this may not always be a valid presumption since the thermal 
stability does not account for the reaction being catalyzed [130].  Instead, the operational 
stability should be measured independently. 
Ideally, the operational stability would be measured in a continuous reactor system such as a 
plug-flow reactor (PFR) or continuous stirred tank reactor (CSTR) under the process conditions 
desired.  Such experiments would yield relevant stability data for biocatalysts to be used in 
processes [130].  But, these experiments are expensive and low throughput.  Conversely, simpler 
batch-wise measurements can  be performed, and these experiments generally involve mixing a 
large amount of substrate with the enzyme and allowing the reaction to progress for many half-
lives of the enzyme [140].  Batch measurements are typically less expensive, but cannot be used 
for all types of biocatalysts. For example, the batch method is limited when there is significant 
substrate or product inhibition, or when substrates cannot be added in large quantities at the onset 
of the reaction.  Thus, a repeated-batch method provides a compromise between these 
approaches.  In such a system, the activity of a biocatalyst is measured in a series of batch 
reactions within a fixed range of substrate concentration [130].  By comparing these activities, 
the point at which 50% of the activity has degraded can be identified as the half-life of the 
biocatalyst.  Here we develop an automated repeated-batch method for measuring the half-lives 
of carbonic anhydrase (CA; EC 4.2.1.1) biocatalysts.  
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CAs are well-studied, Zn
+2
-binding metalloenzymes that catalyze the reversible hydration of 
carbon dioxide (CO2) to bicarbonate (HCO3
-
) and carbonate (CO3
-2
) ions [39] according to the 
mechanism shown below [41]: 
              
     (1) 
                    
  (2) 
       
                    
 
 (3) 
    
       
      (4) 
In this scheme, the reversible deprotonation of bicarbonate (Eqn 4) occurs spontaneously as a 
function of pH, and is not catalyzed by the enzyme.  Nearly ubiquitous in nature, CAs are among 






 [42, 96].  
While most of the prior research on CA has focused on isolation and characterization of these 
enzymes, recent work has explored immobilization of CAs using yeast [141] and E. coli cells [30, 
142] for use as whole-cell biocatalysts.  These catalysts have the benefits of enzyme stabilization 
and enhanced recyclability, while maintaining CO2 hydration activity.  In addition to these 
studies, CA enzymes have been investigated as mediators for carbon capture modalities, 
specifically carbon mineralization [127].  This technique involves the conversion of CO2 into 
carbonate ions and subsequent precipitation with divalent cations such as Ca
+2
.  For example, in 
situ carbon capture from the flue gas of coal-fired power plants has been proposed and studied as 
a potential industrial application of CA enzymes [143].  Other applications for CA enzymes 
include biosensors [50], CO2 fixation for artificial photosynthesis [48], and for biofuel 
production [49].  Despite the breadth of research performed on CAs, operational stabilities have 
not yet been reported.  Some variants of CA possess alternative activities such as esterase 
activity [144] or peroxidase activity upon substitution of the bound Zn
+2
 ion with an Mn
+2
 ion 
[145].  For these special cases, measurement of the stability by a batch method would be possible.  
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However, most forms of CA do not possess these alternative activities, and these activities are 
not related to the hydration activity of CA.  Thus, determining the operational stability of CA 
using esterase or peroxidase activity may not be possible, or may lead to irrelevant results. 
In this report, a method for measuring the operational stability of CA-based biocatalysts is 
described.  The CA isoforms measured were bovine carbonic anhydrase from erythrocytes 
(BCA), carbonic anhydrase beta (Cab from Methanobacterium thermoautotriphicum; PDB: 
1G5C) [45], and carbonic anhydrase methanosarcina (Cam from Methanosarcina thermophila; 
PDB: 1THJ) [51].  In addition to the purified forms of these enzymes, Cab and Cam were also 
tested after immobilization via periplasmic expression using two different periplasmic leader 
peptides (gIII and pelB), as previously described, to generate whole-cell biocatalysts [142].  
These biocatalysts were selected for the various benefits they present.  BCA was chosen because 
it is a commercially available CA that has been studied by several groups in the past.  Cab and 
Cam were selected because they differ in their intrinsic thermal stabilities.  Further, since these 
two isoforms were used in whole-cell biocatalysts, they provide us with the opportunity to 
examine the versatility of our technology, as well as examine the effects of periplasmic 
immobilization on operational stability. 
3.2.3. Materials and Methods 
Materials.  All chemicals, including BCA, were obtained from Sigma-Aldrich (St. Louis, MO) 
unless otherwise indicated.  Nylon tubing and push-to-connect fittings and joints for all gas lines 
were purchased from McMaster-Carr (Robbinsville, NJ). 
Cloning, Expression, and Purification.  Cloning, expression, and purification of all constructs 
were described previously [142].  Cab and Cam used in these experiments were purified from the 
pET-24a vector with no periplasmic leader sequence.  The whole-cell biocatalysts used were 
80 
 
BLR-gCab, BLR-pCab, BLR-gCam, and BLR-pCam where “g” indicates the gIII leader peptide 
is being used, while “p” indicates the pelB leader peptide is used [142].   
Apparatus.  A schematic of the apparatus can be seen in Figure 3-6A. The apparatus consists of 4 
main components: an ethylene glycol-filled water bath with a 250 mL plastic bottle (reaction 
vessel) and two 1 L plastic bottles (saturation vessels), an OMEGA USB-4718 Data Acqusition 
Module (DAQ; OMEGA Engineering, Inc., Stamford, CT), gas flow from compressed 
prepurified N2 and bone dry CO2 cylinders (TechAir, White Plains, NY), and a LabView Virtual 
Instrument (VI; National Instruments, Austin, TX) to control gas switching and record data.  The 
pressure at each regulator outlet is continuously monitored using a pressure transducer 
(Omegadyne Inc., Sunbury, OH) connected to the DAQ.  For each gas, flow is routed through a 
24V, 7W, 175 psi solenoid valve (Peter Paul Electronics Co., Inc., New Britain, CT) before 
being passed through a saturation vessel containing 950 mL deionized water (DI H2O) using a 
stainless steel gas sparger (Valco Instruments Co., Inc., Houston, TX).  This hydrates the gas to 
reduce liquid loss in the reaction vessel.  The solenoid valves are connected to the DAQ and 
switching between the gases is done using a 12V, 15A power relay (Tyco Electronics Corp., 
Wilmington, DE), also connected to the DAQ.  Other components wired to the DAQ are a PHB-
213 pH meter (OMEGA Engineering, Inc., Stamford, CT) and an immersion thermocouple 
(McMaster-Carr, Robbinsville, NJ).  The hydration containers are linked via a T-joint and 
attached to the output is a fritted glass sparger (ACE Glass, Inc., Vineland, NJ). 
Stability measurements.  The filled saturation vessels and reaction vessel containing 100 mL of 
100 mM Tris-HCl pH 9.0 were placed in the glycol bath set to the desired temperature (30
o
C for 
this study).  The pH probe, thermocouple, and glass sparger were placed in the reaction vessel 
and the top was wrapped in Parafilm.  This reduced the loss of volume by evaporation in the 
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reaction vessel.  The VI was activated to initiate control over the apparatus.  The relay was 
plugged in to start gas flow and the outlet pressure of each tank was adjusted to 6 psi.  After the 
desired pH range was entered, data acquisition was started and the baseline was collected for 30-
60 minutes, or until it stabilized.  A pH range of 6.9-7.75 was chosen for this study for its 
consistency and reproducibility under the conditions used.  This is within the effective range of 
Tris buffer which has an approximate pKa of 7.92 at 30
o
C.  However, the pH bounds can be set 
to any values, as long as the pH probe and buffer being used are effective within that range.  





 cells/mL for whole-cell biocatalysts).  The reaction vessel was wrapped in 
Parafilm and the reaction was allowed to proceed for 24-48 hours.  For each run, 2 data files 
were generated: a trace of pH against process time, and the temperature, pressure, and the 
upswing and downswing periods against process time.  The “downswing period” was defined as 
the amount of time required to traverse the defined pH range during the forward reaction (CO2 
sparging).  The “upswing period” is defined the same way, but for the reverse reaction (N2 
sparging).  Sample data obtained using this system can be seen in Figure 3-6. 
Data Analysis.  To represent the operational stabilities of the biocatalysts tested, the half-life was 
selected as the relevant metric.  For each biocatalyst, the plot of downswing period vs. process 
time was fit to the monoexponential decay equation: 
          
     (5) 
where ω is the period at time t, ω0 is the initial period, A is the amplitude constant, k is the decay 
constant, and t is the time.  Using the least-squares method, ω0, A, and k were varied to obtain the 
best fit.  An example of this analysis can be seen in Figure 3-6C. 
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To obtain the half-lives from these fits, Equation 5 was rearranged to solve for t as a function of 
k: 
   
       
 
  (6) 
where χ is the fraction of activity lost (defined as 
    
 ⁄ ) and has possible values of 0< χ<1.  
By substituting a value of 0.5 for χ, the resulting calculation yielded a value in hours representing 
the half-life of the biocatalyst. 
Statistical Analysis.  Half-life results were subjected to an Analysis of Variance (ANOVA) 
statistical test using the General Linear Model using the Minitab program (Minitab, Inc., State 
College, PA).  Post-hoc analysis was performed using a 95% confidence level with the Tukey 
method. 
3.2.4. Results 
Apparatus Properties.  Preparing the system for a new measurement takes approximately 60-80 
minutes, including baseline acquisition.  The system can run with high stability for up to 36 
hours.  After this time, drift in downswing period was sometimes observed, however experiments 
up to 48 hours were possible with this experimental design.    Catalyst addition was performed in 
small increments (20-100 L) to reduce foaming. 



















[146]).  The half-lives of these enzymes can be seen in Table 3-3.  All measurements were 
performed in triplicate.  The errors in these values are the standard deviations from the means.  
Cab was found to have the longest half-life with a mean of 26 hours.  ANOVA on the purified 
enzyme data indicated that the three enzymes are statistically significantly different.  Post-hoc 
analysis revealed that the half-life of Cab is statistically significantly different from both Cam 
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(11 hours) and BCA (4.2 hours).  Cam and BCA were not found to differ to a significant degree, 
likely due to the larger standard deviation in the Cam data. 
Whole-Cell Biocatalyst Stabilities.  Four whole-cell biocatalysts containing periplasmically-


























) [142].  The half-lives of these biocatalysts were found 
to be so long that they were not able to be estimated using the described apparatus.  Throughout 
the range of stable operation of the apparatus, the whole-cell biocatalysts did not decay past the 
linear regime of the monoexponential decay function.  The analysis method requires that the data 
reaches a plateau or at least contains an inflection point so that the data can be fit to equation 5.  
Several numerical methods were explored, however more data would be needed to accurately 
determine the fitting parameters.  Thus, half-life data is not shown for these biocatalysts and they 
are all presumed to be much greater than 48hours.  In order to quantify the half-lives of 
biocatalysts whose operational stabilities outlive the stability of the system, the apparatus would 
need to be modified to enable operation for longer periods of time.   
3.2.5. Discussion 
Operational vs. Thermal Stability.    Cab was determined to have the highest operational stability 
of the purified enzymes which is not surprising as Cab is one of the most thermostable forms of 
CA reported [42].  These results appear to suggest a correlation between the thermal and 
operational stabilities of these biocatalysts.  However, this relationship may not always hold, as 
thermal and operational stabilities can be influenced by different factors. [130, 131].  For 
example, we previously explored thermal stability of the Cam variant by incubation at 95
o
C 
before measuring activity.  This treatment caused similar effects in the free enzyme and whole 
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cell biocatalysts as purified Cam retained approximately 70-81% of its original activity and 
BLR-pCam  retained 65% of its original activity [142].  This is in contrast to the present study 
where the half-life of BLR-pCam was greater than 24 hours while that of purified Cam was 11 
hours.   
Stabilization upon Immobilization.  The results showed that the enzymes were both stabilized 
upon immobilization, as expected [6].  Although the full extent of this stabilization was not 
quantified, each enzyme experienced enhanced operational stability in the whole-cell 
configuration as opposed to their purified forms.  One hypothesis for this stabilization effect is 
that the protein loading within the relatively small volume of the periplasm would cause 
molecular crowding [142].  This would increase the entropic cost of protein unfolding, thus 
increasing protein stabilization. 
Metrics for Reporting Operational Stability.  The operational stabilities of the biocatalysts in this 
study are reported in terms of half-lives.  While this is among the more commonly reported 
metrics for the stability of a biocatalyst [131], this value has been criticized for its limited 
applicability [147] and its relevance to a process [130].  As a preferable alternative, presentation 
of activity vs. process time has been proposed [147].  Using our system, the downswing period 
data vs. time provides such a plot, as seen in Figure 3-6and Figure 3-7, and could also be used to 
describe the stability. 
Another alternative metric could be obtained by first linearizing Equation 5 and plotting the 
period vs. time data according to this linearized form.  By applying a linear fit, the slope of the 
line could be used to indicate the operational stability.  A lower slope would indicate slower 
degradation of activity and thus a more stable biocatalyst.  This would be especially useful for 
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the whole-cell biocatalysts for which the data does not contain an inflection point for fitting the 
monoexponential decay function.   
Potential System Upgrades and Modifications.  In order to measure half-lives of extremely stable 
catalysts, modifications to the apparatus would have to be made to extend the experimental times.  
This would include better control of environmental conditions to stabilize the system volume and 
other modifications to the system hardware.  
In this report, only CA-based catalysts were tested.  However, this apparatus could be used for 
other enzymes with a few modifications.  Enzymes such as monodehydroascorbate reductase 
(EC 1.6.5.4), nitric oxide dioxygenase (EC 1.14.12.17), and sulfur oxygenase/reductase (EC 
1.13.11.55) [148] could be characterized.  Possible modifications include altering the gases to 
dictate reaction direction or using a different ion-selective electrode as opposed to a pH meter.  
Further, this apparatus could be modified to operate at a higher throughput.  By using multiple 
reaction vessels, this method could be used as a screening method for exploring variants or 
mutants for increased operational stability, activity, etc. 
Finally, we believe this technology can pave the way towards answering some fundamental 
questions about operational stability of biocatalysts, particularly those with CA activity.  For 
example, using this method, the half-life could be determined as a function of temperature, pH, 
and reaction rate (by way of varying the substrate concentration).  In doing so, the biocatalysts 
could be evaluated for their inherent properties, as well as their potential performance under 
operating conditions for implementation into a process.  Such studies are rarely found in current 
literature, but with this method understanding the effects of environmental conditions on 




Described in this report is an automated method for measuring the operational stability of CA-
based biocatalysts.  Homogeneous (purified enzymes) and heterogeneous biocatalysts (whole-
cells) were characterized using this method.    By utilizing constant data monitoring and 
automatic switching between the forward and reverse reactions, long reaction times requiring 
little monitoring were possible.  This repeated-batch method enables the simple and low-cost lab-
scale testing of many enzymes, including CA.  Our results found that Cab had the longest half-
life compared to the other purified enzymes, and that immobilization of Cab and Cam in the 
periplasmic space extended the half-life beyond the limits of our experimental device.  This 
repeated-batch method will be a useful tool for exploring different biocatalysts with CA or 
related activities.   
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3.2.8. Figures and Tables 
 




(A) Schematic representation of the apparatus showing all essential components.  In this drawing, 
both electrical wiring ( ) and tubing for gas flow ( ) are shown. (B) Trace of pH 
against process time with several cycles shown. (C) Downswing period (  ; forward reaction; 
CO2 bubbling) against process time with monoexponential fit ( ) used to calculate half-life 
for BCA.  The period indicates the amount of time required to pass between the pH setpoints.  
Thus, the increase in period over time shown indicates a degradation of activity as time passes.  








Downswing period (  ; forward reaction; CO2 bubbling) against process time for (A) purified 
Cam, (B) BLR-gCam, and (C) BLR-pCam.  The data for purified Cam (A) could be fit by a 
monoexponential equation and the fit to the data is shown ( ). When Cam was stabilized 
upon immobilization, the data was linear (B & C) and could not be fit by the monoexponential, 
indicating half-lives beyond the capabilities of the experimental apparatus.  









BCA 4.2 ± 1.3 
Cab 26 ± 5
b
 
Cam 11 ± 5 
a
Measurements were performed in triplicate, errors represent standard deviations. 
b





4. Engineering Outer Membrane Permeability 
 
Note: A version of this chapter will be included in a future manuscript, currently in review.  
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4.1. Abstract 
The limited permeability of the E. coli outer membrane can significantly hinder whole-cell 
biocatalyst performance.  In this study, the SARS coronavirus small envelope protein (SCVE) 
was expressed in E. coli cells previously engineered for periplasmic expression of carbonic 
anhydrase (CA) activity.  This maneuver increased small molecule uptake by the cells, resulting 
in increased apparent CA activity of the biocatalysts.  The enhancements in activity were 
quantified using methods developed for traditional heterogeneous catalysis.  The expression of 
the SCVE protein was found to significantly reduce the Thiele moduli (), as well as increase the 
effectiveness factors (), effective diffusivities (De), and permeabilities (P) of the 
biocatalysts.  These catalytic improvements translated into superior performance of the 
biocatalysts for the precipitation of calcium carbonate from solution which is an attractive 
strategy for long-term sequestration of captured carbon dioxide.  Overall, these results 
demonstrate that synthetic biology approaches can be used to enhance heterogeneous catalysts 
incorporated into microbial whole-cell scaffolds.  
4.2. Introduction 
Gram-negative bacteria, such as Escherichia coli, have been previously shown to be less 
permeable than gram-positive bacteria, largely due to their outer membrane [149].  The native 
permeability through the outer membrane arises from porin proteins.  The hydrophobic 
transmembrane α-helical domains of these proteins form tightly associated trimeric bundles that 
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form non-specific molecular transport channels [150-155].  Monomeric molecular weights of 
native porins can range from 28 to 48 kDa [154].  Common porins include OmpF, OmpC, and 
PhoE.  Among all of the proteins within a cell, these are often the most prevalent on a mass basis.  
They typically form 10
5
 channels per cell or more [152].  Transport through these channels is 
highly dependent on the properties of the solute, including physical size, charge, and 
hydrophobicity.  In general, a typical porin generates a pore roughly 0.9-1.1 nm in diameter, and 
excludes molecules above 0.6 kDa [150, 155].  In addition to porins, specific channels also exist 
in the outer membrane for the transport of maltose and maltodextrans (LamB), nucleotides (Tsx), 
and ferrichrome (FhuA), among others [151]. 
Despite the presence of native porins, several chemical [156-159], biological [156, 157, 160-163], 
and genetic[156, 164-167] treatments have been explored for outer membrane permeabilization.  
In most cases, these experiments were performed to better understand the structure and function 
of the outer membrane.  More recent studies have examined the impact of permeabilization on 
biocatalysis [168], as well as other whole-cell bioprocesses such as nutrient uptake [38].  One 
promising approach is the use of viroporins, which are a diverse class of viral proteins that 
further permeabilize the membranes of host cells [169-171].  Some viroporins encoded by 
bacteriophages are also referred to as holins [172].  Viroporins are similar to porins in that they 
oligomerize within the membrane to form pores, and  this oligomerization often occurs between 
the hydrophobic, transmembrane, α-helical domains of the proteins [170].  Archetypal viroporins 
include the Picornavirus P2B, HCV p7, IAV M2, and HIV-1 Vpu proteins [171].  Viroporins 
also possess similar exclusion sizes to porins, only allowing diffusion of small molecules [173].  
The recombinant expression of viroporins in E. coli has been previously studied by several 
research groups, as indicated above.  In these previous studies, the primary focus was the 
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structure of the protein and the pore formed by oligomerization of the transmembrane domains.  
Characterization of the effects of introducing these new pores into the outer membrane was 
largely limited to the diffusion of various small molecules across the membrane. 
As the field of synthetic biology matures, it is becoming clear that we are just beginning to 
understand of the extent to which biological systems and parts can be designed, modified and 
utilized to address critical needs.  Recent examples include engineering of advanced batteries 
from biological templates, enzymatic biomaterials, biological logic gates, and many other 
advances are clearly on the horizon.  Here we explore the use of synthetic biology to create 
heterogeneous catalysts for the capture of carbon dioxide, which will be critical as we move 
towards the capture and utilization of carbon dioxide, or even the permanent sequestration of 
carbon dioxide from the atmosphere.  To accomplish this goal we have previously expressed CA 
enzymes in the periplasm of E. coli, and here we report on the improvements in this system that 
can be obtained by reducing transport limitations via further genetic manipulation of the cells. 
In this study, the SARS (severe acute respiratory syndrome) coronavirus envelope (SCVE) 
protein was evaluated for its ability to permeabilize the outer membrane of E. coli.  The 76 
amino acid SCVE protein is predominantly hydrophobic and each monomer contains one 
transmembrane domain, which when expressed on its own, can oligomerize into dimeric, 
trimeric, or pentameric bundles [174].  However, when the full protein is expressed, only 
homopentamers are observed in vivo [175].  These bundles were determined to be formed due to 
two cysteines at positions 40 and 44.  Mutations at these sites rendered the protein inactive and 
unable to form transmembrane pores [173].  Inhibition of pore formation was also seen in the 
presence of hexamethylene amiloride (HMA) [176].  The pores formed by the SCVE protein are 
estimated to have a radius of about 0.6 nm [174], and preferentially facilitate transport of 
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monovalent cations as opposed to monovalent anions [177].  Recently, SCVE was expressed in E. 
coli and was shown to improve the diffusion of two different small molecules across the outer 
membrane [173].  Therefore recombinant expression of SCVE is a promising approach for 
modulating transport across the outer membrane of E. coli. 
Whole-cell biocatalysts containing carbonic anhydrase (CA; EC 4.2.1.1) as their enzymatic 
component have recently emerged as a cost-effective method for catalyzing the hydration 
reaction of carbon dioxide (CO2) [30, 141, 142, 178].  CAs are Zn
+2
-binding metalloenzymes 
that are able to reversibly catalyze the hydration of aqueous CO2 via the reaction mechanism 
below, where “EZn” represents the enzyme molecule and the bound Zn+2 ion [39, 41]: 
              
     (1) 
                    
  (2) 
       
                    
 
 (3) 
    
       
      (4) 
Two isoforms of CA were selected for this study:  carbonic anhydrase beta (Cab; 
Methanobacterium thermoautotriphicum; PDB 1G5C) [45] and carbonic anhydrase 
methanosarcina (Cam; Methanosarcina thermophila; PDB 1THJ) [51].  We have previously 
reported the  periplasmic expression of these isoforms in E. coli, resulting in functional whole 
cell biocatalysts, however the activity was decreased as compared to the activity of the purified 
enzymes due to membrane transport limitations [142].  
Therefore, in this study the whole-cell biocatalysts were modified by SCVE expression and 
subsequently characterized.   Disruption of the outer membrane resulted in increased uptake of 
94 
 
the small molecule NPN, but also slowed the growth of the cells, indicating diminished cell 
health.  The improvement in a CA-based biocatalyst upon SCVE expression was evaluated by 
kinetic and functional activity.  Expression of SCVE resulted in an increase in per-cell apparent 
activity as well as an increase in carbonate precipitation with both isoforms of periplasmically 
expressed CA. 
The ability to separately alter activity and transport in the whole cells via genetic engineering 
opens the door to better biocatalyst design, and thus we explore the impact of the 
permeabilization on heterogeneous catalysis via estimation of the Thiele modulus and 
effectiveness factor for the system.   
4.3. Materials and Methods 
Materials.  Chemicals were obtained from Sigma-Aldrich (St. Louis, MO), unless otherwise 
stated.  Custom oligonucelotides were synthesized by Integrated DNA Technologies (IDT; 
Coralville, IA).  Enzymes used in cloning were purchased from New England Biolabs (NEB; 
Ipswich, MA).  Isopropyl β-D-1-thiogalactopyranoside (IPTG) was obtained from Promega Corp. 
(Madison, WI).  BLR(DE3) E. coli cells were from Novagen (Billerica, MA). 
Cloning.  The SCVE gene was synthesized by Epoch Life Science (Sugarland, TX).  
Oligonucleotides TP55 and TP56 were used to amplify the gene.  The PCR product was then 
digested using the BamHI and EcoRI restriction enzymes.  The destination vector pET-2Z 
(Plasmid 29776; Addgene, Cambridge, MA) was similarly digested and gel-extracted.  The 
digested SCVE fragments were ligated into the digested pET-2Z vector using T4 DNA Ligase, 
resulting in the plasmid pET2Z-SCVE.  BLR(DE3) E. coli cells were transformed with this 
plasmid by electroporation and selected on agar plates containing 50 g/mL spectinomycin.  The 
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pET2Z-SCVE plasmid was also transformed into BLR-gCab or BLR-gCam cells and selected on 
agar plates containing 50 g/mL spectinomycin and 50 g/mL ampicillin.  The SCVE DNA and 
amino acid sequences, as well as the two primer sequences used for cloning can be found in 
Table S4-1and Table S4-2. 
Protein Expression.  SCVE was expressed at 37
o
C in 10 mL of Luria Broth (LB) supplemented 
with 50 g/mL spectinomycin.  Cells containing gCab or gCam as well as SCVE were expressed 
in similar conditions, but also contained 50 g/mL ampicillin.  Cultures were inoculated by 
diluting overnight cultures at a 1:50 ratio.  SCVE expression was induced with1 mM IPTG at 
OD600=0.6.  Induction of gCab and gCam was performed by concurrently adding 0.02% L-
arabinose and 1 mM ZnCl2.  After 4 hours of expression, the cultures were pelleted by 
centrifugation at 3,000xg for 10 minutes.  The pellets were resuspended in the buffer appropriate 
for the various assays described below. 
NPN Assay.  Several versions of a 1-N-phenylnaphthylamine (NPN) uptake assay have been 
described previously [179-181].  The basic principle is substrate fluorescence upon interaction 
with the inner lipid membrane and an increase in diffusivity would result in an increase in 
fluorescence.  Here, the whole-cell biocatalysts were resuspended in 5 mM HEPES pH 7.2.  A 
stock solution of NPN containing 5 mM NPN in acetone was diluted to 50 M in 5 mM HEPES 
pH 7.2.  In a black 96-well plate, 50 L of 5 mM HEPES pH 7.2 and 100 L of the cell 
suspensions were mixed.  To initiate the reaction, 50 L of the diluted NPN solution was added 
to the wells.  After incubation at 25
o
C for 3 minutes, the fluorescence was measured using 
excitation and emission wavelengths of 355 nm and 405 nm, respectively, in a SpectraMax M2 
spectrophotometer (Sunnyvale, CA). 
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Kinetic Assays.  The stopped-flow kinetic assay used was previously described [142].  Briefly, 
solutions of 55.6 M m-cresol purple were saturated with CO2 and N2 via bubbling of each 
compressed gas through a glass gas dispersion tube (Ace Glass, Vineland, NJ) at 25
o
C.  These 
solutions were mixed to vary the concentration of CO2 from 3 to 28 mM.  The whole-cell 
biocatalysts were diluted in 100 mM Tris at pH 9.0.  The concentration of cells in each solution 
was determined by measuring their optical densities at 600 nm.  Using a BioLogic stopped-flow 
apparatus (BioLogic, Claix, Isère, France) attached to a Jasco J-815 CD Spectrometer (JASCO, 
Easton, MD), the absorbance at 578 nm was monitored.  The data was fit to the differential form 
of the Michaelis-Menten equation using the Berkeley Madonna software [119].  Each 
measurement was baseline-corrected by the activity of BLR cells expressing no recombinant CA. 
CaCO3 Precipitation.  The precipitation assay used was previously described [142].  Briefly, 5 
mL of 1 M Tris pH 9.0 was placed in a 15 mL centrifuge tube (Corning, Inc., Tewksbury, MA).  
After adding the biocatalyst being tested, compressed CO2 gas was bubbled through each 
solution for 30 seconds using a glass gas dispersion tube.  Immediately after bubbling, calcium 
chloride (CaCl2) and calcium carbonate (CaCO3) were added to the solution.  After incubation at 
25
o
C for 1 hour, the suspension was passed through a spin column (Epoch Life Science, 
Sugarland, TX) on a vacuum manifold (Qiagen, Valencia, CA).  Once they dried, the columns 
were weighed to determine their total mass.  The amount of CaCO3 generated in each sample 
was determined by subtracting the initial mass of the spin column, the mass of cells added, and 
the mass of CaCO3 added.   
Statistical Analysis.  Analysis of variance (ANOVA) was performed using the Minitab program 
(Minitab Inc., State College, PA).  The general linear model (GLM) and the Tukey Method were 




Expression of SCVE.  The SCVE gene was cloned into the pET-2Z vector and this was 
transformed into BLR(DE3) cells, as well as cells containing CA-encoding plasmids using 
orthogonal antibotics for selection.  The presence of both plasmids in the cells was verified by 
PCR amplification of both genes.  The three whole-cell biocatalysts were named BLR-SCVE, 
BLR-gCab/SCVE, and BLR-gCam/SCVE.  Differential induction of the two different transgenes 
was accomplished with IPTG for SCVE and arabinose for CA.   
Growth Inhibition Curves.  To demonstrate the effect of SCVE expression on cell viability and 
growth rates, the OD at 600nm of the induced and uninduced cultures were measured every hour 
for 4 hours Figure 4-1).  As expected [173], the induced cultures exhibited slower growth as 
compared to uninduced controls.  After 4 hours, the uninduced control cells reached a mean 
OD600 of 3.6.  Conversely, BLR-SCVE, BLR-gCab/SCVE, and BLR-gCam/SCVE reached mean 
final OD600 values of 2.7, 2.0, and 2.3, respectively.  The diminished growth is indicative of 
SCVE protein expression. 
NPN Permeability.  The NPN assay was used to quantify small molecule transport across the 
outer membrane.  The uptake factors, calculated by dividing the background-corrected 
fluorescence value of each sample by the background corrected fluorescence of NPN alone [179], 
of induced and uninduced cells harboring the pET2Z-SCVE plasmid can be seen in Figure 4-2.  
Native BLR cells harboring no recombinant plasmids yielded an uptake factor of 8.0 ± 0.3.  
BLR-SCVE, BLR-gCab/SCVE, and BLR-gCam/SCVE cells exhibited uptake factors of 9.4 ± 
0.2, 9.1 ± 0.5, and 8.5 ± 0.2, respectively.  ANOVA on this data indicated a statistically 
significant difference between the uptake factors of the control cells and each of the 
permeabilized cells. Post-hoc analysis revealed no statistically significant difference between 
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BLR-SCVE and BLR-gCab/SCVE cells.  These results confirmed that small molecule transport 
across the outer membrane of E. coli cells was enhanced after expression of the SCVE protein. 
Enhanced CA Activity.  To determine the effect of the SCVE proteins on CA-activity of the 
whole-cell biocatalysts, apparent activity measurements were performed.  The Michaelis-Menten 
kinetic parameters for native and altered whole-cell biocatalysts can be seen in Table 4-1 - 
Kinetic parameters w/ and w/o SCVE.  The apparent parameters for unpermeabilized BLR-gCab 
and  BLR-gCam were previously published [142].  The rates of the cells expressing the SCVE 
protein were corrected for the reaction rates of BLR-SCVE cells, which contain no recombinant 
CA.  For the 4 whole-cell biocatalysts evaluated, almost no difference in the apparent KM was 
seen (38 mM for BLR-gCab and BLR-gCab/SCVE; 31 mM for BLR-gCam and 34 mM for 
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for BLR-gCam).  These results translate into 29% and 45% enhancements in apparent rate for 
BLR-gCab/SCVE and BLR-gCam/SCVE cells, respectively, as compared to BLR-gCab and 
BLR-gCam cells, respectively.  Since Cam is the more active CA isoform, it is reasonable to 
expect cells harboring Cam to experience a larger degree of enhancement upon permeabilization.  
Also, due to lower levels of protein loading in these cells [142], it is not surprising that the 
apparent kinetic values do not exceed those of BLR-gCab/SCVE.  For both Cab and Cam, these 
results indicate an increase in diffusion rates of substrate and product across the outer membrane 
produces increases in the overall apparent reaction rates. 
Increased Functional Activity.  A model system for carbon mineralization was explored to 
demonstrate the functional utility of the biocatalysts.  Carbon mineralization is a process by 
99 
 
which CO2 is converted to carbonate ions, which combine with divalent cations and precipitate 
as a thermodynamically stable salt [141].  The mineralization capabilities for the biocatalysts 
generated in this study were determined by converting gaseous CO2 into calcium carbonate.  The 
masses of CaCO3 precipitated in the presence of various whole-cell biocatalysts can be seen in 
Figure 4-3.  BLR and BLR-SCVE cells expressing no recombinant CA exhibited similar 
amounts of precipitation, with means of 0.14 and 0.13 g, respectively.  The remaining whole-
cells yielded mean masses of 0.17, 0.18, 0.23, and 0.24 g of CaCO3 precipitated for BLR-gCab, 
BLR-gCam, BLR-gCab/SCVE, and BLR-gCam/SCVE, respectively.  These values represent 
improvements in carbon mineralization of 35% and 33% for BLR-gCab and BLR-gCam, 
respectively, upon SCVE expression. 
Two-way ANOVA on this data revealed that cells expressing recombinant CA exhibited 
statistically significantly higher levels of precipitation than those containing no CA.  Also, 
whole-cell biocatalysts expressing the SCVE protein were found to be statistically significantly 
different from cells not expressing the protein.  Post-hoc analysis revealed no statistical 
significance in the difference between BLR-gCab/SCVE and BLR-gCam/SCVE, BLR-gCab and 
BLR-gCam, or BLR and BLR-SCVE cells.  These results definitively show an improvement in 
CO2 hydration and mineralization upon concomitant expression of CA and SCVE. 
4.5. Discussion 
The ability to modify both the activity and transport in the biocatalysts allows for the 
characterization of the system using classical methods developed in the heterogeneous catalysis 
literature.  The effectiveness factor () [182] is defined as the whole-cell activity divided by the 
activity of an equivalent amount of enzyme with no transport barrier.  In order to determine the 
equivalent amount of enzyme for a given number of whole-cell biocatalysts, previously 
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published values for periplasmic enzyme loading were used [142].  The effectiveness factor can 
also be used to calculate the Thiele modulus (), a dimensionless parameter that relates the 
diffusivity and reaction rate of a catalyst [182]. 
The Thiele modulus is obtained by performing a dimensionless shell balance on the catalyst 
considering both diffusion and reaction within the shell.  Assuming a spherical catalyst with 
Michaelis-Menten kinetics, the non-dimensionalized differential equation resulting from this 
derivation is: 
   






   
 
    
   (5) 
where: 
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  (7) 
In Equations 5-7,  is the non-dimensionalized concentration (C/CS),  is the non-
dimensionalized radius (r/R), R is the radius of the catalyst, De is the effective diffusivity of the 
catalyst, and CS is the bulk concentration of reactant (CO2) in the extracellular space.  Equation 5 
can be solved numerically to determine the non-dimensionalized concentration profile in the 
periplasm for each biocatalyst.  For a full derivation of these expressions and the concentration 
profiles for each whole-cell biocatalyst evaluated, please refer to the Supplementary Information.  
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To obtain a value for , the following relationship between the effectiveness factor and Thiele 





   
 
√          (8) 
Once the Thiele modulus was calculated, Equation 6 was solved for De, which was then 
calculated.  It should be noted here that in these derivations, the specific effects of the outer 
membrane and periplasmic space are not decoupled.  Instead, the membrane and periplasm are 
considered together, so the parameters calculated are for the overall system.  Further, bulk 
diffusion of the substrate to the surface of the particle was not considered when calculating the 
effectiveness factor.  It was assumed that this bulk diffusion exists in both the whole-cell and 
free enzyme scenarios and this would cancel each other out.  Thus,  only applies to substrate 
molecules that have reached the biocatalyst interface, not all of the substrate molecules in the 
reaction solution. 
The last parameter calculated to describe the whole-cell biocatalysts was the permeability (P) of 
the outer membrane to CO2.  The theoretical permeability of BLR-gCab and BLR-gCam was 















/sec) [185], d is the membrane thickness 
(7.8 x 10
-3
 µm) [186], a0 is the cross-sectional area of all of the pores present in the outer 
membrane (0.113 µm
2
) [184], A is the total surface area of the outer membrane (3.00 µm
2
) [184], 
and a/a0 is the Renkin correction factor, a relationship between the effective pore area (a) and a0.  
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where rCO2 is the solute radius and Rp is the pore radius (5.8 Å) [184].  The solute radius of CO2 
was calculated by:[187] 
     √
  
     
 
  (11) 
where M is the molecular weight of the solute (44 g/mol), ρ is the density of a solution of the 
solute being evaluated (ρCO2= ρH2O = 1 g/mL), and NA is Avogadro’s number.  Once P was 
calculated for BLR-gCab and BLR-gCam, it was used to calculate P for the cells expressing the 
SCVE protein.  To do so, the following expression was used to determine a partition coefficient 
(K) as a function of De for both biocatalysts [188]. 
  
   
 
 (12) 
Then, using the De for each SCVE-expressing biocatalyst and its corresponding K, the 
permeability for the permeabilized cells was calculated.  Table 4-2 contains the values for , , 
De, and P for the 4 whole-cell biocatalysts quantified using these calculations. 
The calculations show an increase in effectiveness factor of about 100% upon permeabilization 
with SCVE expression for biocatalysts containing both Cab and Cam.  This roughly translates 
into a 50% reduction in the Thiele modulus, a 3.5-fold increase in diffusivity, and an increase in 
permeability of about 2.5-fold.  The biocatalyst found to have the highest permeability was BLR-
gCam/SCVE, for which P was found to be approximately 4.4 x 10
3
 µm/sec.  The calculated 
permeability was used to estimate the expression yield necessary to obtain such a value.  By 
using the properties of an SCVE-generated pore described above, it was estimated that the 
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expression yield would be 18 mg of SCVE per L of culture in order to achieve this permeability.  
Previously published reports have shown recombinant porin expression yields of 20-25 mg/L of 
culture in E. coli [189, 190].  Another report of outer-membrane protein expression showed a 
yield of 12 mg/L of culture after purification [191].  Given that the protein recovery from each 
step required in protein purification could be as low as 70% [192], the actual yield could be 
much higher.  Finally, the expression of native outer membrane proteins such as OmpA, OmpX, 
and OmpT have been shown to reach yields of 150-170 mg/L of culture in E. coli [193].  Thus, 
the estimated protein yield seems reasonable and consistent with values found by other groups. 
4.6. Conclusions 
Recombinant expression of the SCVE viroporins in E. coli resulted in the improvement of CA-
based whole-cell biocatalysts.  By introducing additional pores to the outer membrane of the 
cells, the diffusivity of small molecules across the outer membrane was enhanced.  This 
translated into increased apparent catalytic activity.  These improvements were measured 
experimentally, the data from which was then used to quantify the enhancement using principles 
of diffusion-reaction systems.  This system could very easily be applied to other biocatalysts 
whose catalytic components (most commonly enzymes) are relegated to the periplasmic space of 
the cell.  Overall this work demonstrates that synthetic biology techniques can be used to design 
and build improved heterogeneous catalysts which will facilitate applications such as carbon 
capture and sequestration. 
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4.8. Figures and Tables 
 




Growth retardation curves presented as OD600 vs. Time post-induction for all whole-cell 
biocatalysts evaluated.  All measurements were performed in triplicate, with the error bars 





Figure 4-2 - NPN Uptake Factors w/ and w/o SCVE 
 
 
1-N-phenylnaphthylamine (NPN) uptake factors for the various whole-cell biocatalysts evaluated.  
Uptake factors are defined as the fluorescence of the biocatalyst divided by the fluorescence of 
the NPN solution alone.  All measurements were performed in triplicate, with the error bars 









*Indicates statistically significant increase in uptake factor relative to controls 
Calcium carbonate (CaCO3) precipitation amounts for the various whole-cell biocatalysts 
evaluated.  In each case, the cells were tested (a) without SCVE expression, and (b) with SCVE 
expression.  All measurements were performed in triplicate, with the error bars representing the 
standard deviations from the means. 

























 2.5 ± 0.6 x 10
-7
 38 ± 5 6.5 x 10
-9
 
BLR-gCab/SCVE 3.2 ± 0.4 x 10
-7





 1.9 ± 0.4 x 10
-7
 31 ± 3 6.0 x 10
-9
 
BLR-gCam/SCVE 2.7 ± 0.5 x 10
-7




Previously published values [45] 
Measurements were performed in triplicate, with errors indicating standard deviations from the 
means. 
 
Table 4-2 - Calculated diffusion-reaction parameters w/ and w/o SCVE 
 




) PCO2 (m sec
-1
) 
BLR-gCab 0.21 22 0.83 x 10
-3
 1.7 x 10
3
 
BLR-gCab/SCVE 0.43 11 2.9 x 10
-3
 4.1 x 10
3
 
BLR-gCam 0.28 17 2.0 x 10
-3
 1.7 x 10
3
 
BLR-gCam/SCVE 0.58 8.1 7.3 x 10
-3








4.9. Supplementary Information 
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Table S4-2 - Primers for SCVE cloning 
Primer Description Sequence 
TP55 SCVE Forward BamHI AGT GAC GGA TCC ATG TAT AGC TTT GTG AGC 
TP56 SCVE Reverse EcoRI AGT GAC GAA TTC TTA CAC CAG CAG ATC C 





Derivation for obtaining Thiele Modulus with Michaelis-Menten Kinetics 
The following derivation is adapted from one that has been previously published for porous 
spherical catalysts with first-order kinetics [182]. 
 




Reaction/Diffusion Shell Balance 
      
 |        
 |          
             
Divide the whole equation by 4r and take the limit as r -> 0 
 
  
     
      
           
Fick’s Law of Diffusion:  
       
  
  
        
Substitute Equation 3 into Equation 2:  
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Differentiate the first term of Equation 4 and simplify to remove coefficient of second derivative: 
     
  
  
    
 
   
   
    
           
   









          
110 
 
Set the boundary conditions to be:  
  
  
                         
In order to obtain the Thiele Modulus from Equation 6, it first needs to be nondimensionalized 




    
 
 
        
Nondimensionalizing the boundary conditions as well yields: 
  
  
                        




















         
   




















   
   
         
Nondimensionalize the Michaelis-Menten equation: 
   
     
    
 
       
      
 
     
  
  




     
  






     
    





         
Substitute Equations 10, 11, and 12 into Equation 6: 
  
  
   













     
    
           
Simplify to remove the coefficient of the second derivative as before to obtain: 
   






   
 
    
           
Where the Thiele Modulus is represented by: 
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This expression for the Thiele Modulus was confirmed with another previously published 
derivation, achieved by a different method [194]. 
The following numerical approach for solving Equation 15 (a non-linear second-order 
differential equation) is adapted from a method previously published [183].  To numerically 
solve the equation, it must first be split into 2 first-order differential equations.  A new variable 









   




    
 
    
         
This transformation also requires transforming the boundary conditions: 
       
  
 
                  
where 
  
 ⁄  is the lower boundary that defines the start of the periplasmic space.  For this 
solution, this parameter was set at 0.9, indicating that the periplasm’s thickness is the outer 10% 
of the cell’s radius.  The boundary value problem defined by Equations 17, 18, and 19 was 
solved using the MATLAB software (R2009b, MathWorks, Natick, MA).  The code used, which 
appears in Figure S4-2, is a modified version of previously written code [195].   
 
Figure S4-2 - MATLAB code used to solve 2nd order BVP 
function bvp4 
%x represents lambda, y represents psi 
xlow=0.9; xhigh=1;  %sets shell across which profiles are calculated 
solinit=bvpinit(linspace(xlow,xhigh,10),[0 1]); %defines mesh and initial 
guesses 
sol=bvp4c(@bvp4ode,@bvp4bc,solinit); 
xint=linspace(xlow,xhigh,20);  %defines linspace for solution 
Sxint=deval(sol,xint);         %evaluates solution 
plot(xint,Sxint(1,:))   %plots psi vs lambda 
%------------------- 
function dydx=bvp4ode(x,y)  %defines ODEs 
a=22;   %thiele modulus - varies by biocatalyst 
b=0.87; %beta as defined in Equation 13 - varies by biocatalyst 
dydx(1,1)=y(2); %the first first-order ODE 
dydx(2,1)=-(2/x)*y(2)+(a^2)*(y(1)/(1+b*y(1))); %the second first-order ODE 
%------------------- 
function res=bvp4bc(ya,yb)  %defines boundary conditions 




Equation being solved is defined in Equation 15 above. 
 
The resulting solution for each of the 4 biocatalysts tested can be seen in Figure S4-3.  In this 
plot, biocatalysts with higher diffusivities, and thus higher overall reaction rates, result in flatter 
nondimensionalized concentration profiles.  This is because with increased permeability, the 
periplasmic and extracellular spaces are able to more easily equilibrate, and thus the gradient 
between the two spaces is decreased. 
 
Figure S4-3 - Concentration profiles for cells w/ and w/o SCVE 
 
 






Derivation for relationship between  and  with Michaelis-Menten Kinetics 
To begin, we define the effectiveness factor in general terms: 
  
                     
                                     
         
Next, apply those terms to our whole-cell biocatalysts. 
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Where Ap and Vp are the surface area (4R2) and volume (4R3/3), respectively.  Substituting in 
these expressions and simplifying gives: 
  
   
     






   
)         
In order to simplify this expression further, we need an expression for the final term.  To obtain 
such an expression, we begin with the same shell balance above: 
      
 |        
 |          
             
Divide by 4r2r , take the limit as r -> 0, substitute Fick’s Law of Diffusion for WAr and the 
Michaelis-Menten rate equation for rS: 
  
   
   
 
     
    
         
Using the chain rule, apply the transformation: 
   











         







     
  
 
    
           









     
  
∫




           
In order to integrate this function, a u-substitution must be used where: 
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Substitute Equation 31 into Equation 23 and then substitute Equation 13 where necessary: 
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5. Improved Functionality of Whole-cell Biocatalysts 
 
Note: A version of this chapter entitled “Surface display of small peptides on Escherichia coli for enhanced calcite (CaCO3) precipitation rates.” 
has been accepted for publication in Biopolymers: Peptide Science (2014) and is currently in press. 
 
TNP designed and performed all experiments, analyzed the data, and wrote the manuscript. 
 
5.1. Abstract 
Mineralization has emerged as a promising strategy for long-term carbon sequestration. These 
processes involve carbon dioxide hydration followed by mineral precipitation.  We have 
explored the production of whole-cell biocatalysts engineered with carbonic anhydrase (CA) 
activity to accelerate the CO2 hydration reaction.   In this study, short polypeptides were 
displayed on the surface of E. coli cells and whole-cell biocatalysts containing periplasmically 
expressed CAs in an attempt to enhance calcite mineral formation.  It was found that cells co-
expressing recombinant periplasmic CA and surface-displayed GPA peptide (PEVPEGAFDTAI) 
outperformed other peptide-expressing biocatalysts evaluated in terms of the amount of 
precipitate formed, as well as the overall formation rate of solids.  Cells expressing the Cab CA  
isoform (BLR-pCab) and Cam  isoform (BLR-pCam)  with the surface-displayed GPA peptide 
exhibited 36% and 67% improvements in precipitation amounts, as well as 18% and 60% 
improvements in overall formation rates, respectively, over similar biocatalysts without GPA 
expression.  These results demonstrate that synthetic biology approaches can be used to create 
novel biocatalysts with the ability to enhance both catalysis and precipitation activities. 
5.2. Introduction 
There has been recent interest in the development of chemical processes using ambient CO2 but 
the hydration of CO2 can be a rate limiting step in liquid-phase reactions.  We have been 
interested in the mineralization of CO2, a process in which gaseous CO2 is captured and stored in 
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mineral carbonates, primarily calcite (CaCO3) [196-198].  One method to accelerate CO2 
hydration is through the use of  carbonic anhydrases (CA; EC 4.2.1.1) [143], a class of enzymes 




 [41].  CAs are ubiquitous metalloenzymes with bound 
Zn
+2







 [42].  Several groups have used CAs to generate whole-cell biocatalysts in yeast [141] and 
E. coli [30, 142, 178] for carbon mineralization.  In many of these studies, the biocatalysts have 
been shown to increase the amount of calcite formed.  However, we believe there is an 
opportunity for further improvement by enhancing calcite precipitation rates in addition to the 
amount of precipitate generated. 
The precipitation of a solid compound can usually be divided into three distinct processes: 
supersaturation of the solution, nucleation, and growth [199].  Once the concentration of a given 
compound exceeds its solubility at a set of conditions (supersaturation), interactions between the 
dissolved molecules result in a phase transition from an aqueous to a solid state (nucleation) 
[200].  Subsequently, these nucleated molecules form “active sites” on which additional 
molecules spontaneously deposit (growth) [199].  In general, precipitation is a thermodynamic 
process by which the Gibbs free energy of a supersaturated solution is minimized.  Although 
there are entropic penalties associated with this organization of molecules, the energetic benefits 
outweigh these effects [200]. 
Efforts to manipulate calcite precipitation have previously employed natural proteins from sea 
creatures [201, 202], as well as synthetic materials [199], and peptides, primarily poly-aspartate 
[203, 204] which has a strong negative charge, but others as well [205].  When added to a 
solution containing calcium and carbonate ions, these materials were able to alter the 
morphology of the crystals formed, but in many cases the precipitation rates were decreased.  
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However, immobilization of poly-aspartic acids on a solid support made of chitosan was shown 
to improve the rate of calcite formation [202].  Further, yeast surface display of the GPA peptide, 
which is derived from the calcium-binding site of glycophorin A [206] was shown to increase the 
amount of precipitate formed, but the kinetics of this process were not evaluated [141]. 
In this study, a poly-aspartate 20-mer (D20), the GPA peptide, and the FLK peptide were 
immobilized on the surface of E. coli cells via fusion to the C-terminus of the eCPX protein 
[207].  The FLK peptide is a 12-mer peptide with 4 repeats of the amino acid sequence FLK 
[141].  This peptide has a net positive charge, and was used as a negative control.  A FLAG 
peptide tag was fused to each peptide for verification of successful surface expression and thus 
cells expressing the FLAG tag alone were also investigated.  The eCPX protein used for cell-
surface display was created via circular permutation of the native OmpX membrane protein, 
which allows both termini of the eCPX protein to be exposed to the extracellular space.  We 
hypothesize that expression of these peptides on the surface of the bacteria cells places them in a 
region of high CO3
-2
 concentration, enabling them to enhance the amount and formation rate of 
calcite crystals.  Of the peptides cloned, all but D20 successfully expressed under the conditions 
used.  Of those that expressed, the highest level of calcite precipitation was seen in the presence 
of the GPA peptide.  This fusion was then also expressed in whole-cell biocatalysts containing 
the Cab (Methanobacterium thermoautotriphicum; PDB:1G5C) [45] and Cam (Methanosarcina 
thermophila; PDB:1THJ) [51] isoforms of CA periplasmically expressed using the pelB leader 
peptide.  These biocatalysts were named BLR-pCab and BLR-pCam [142].  Using these surface-
modified whole-cell biocatalysts, the precipitation amounts and overall formation rates were 
improved to a significant degree over their unmodified counterparts. 
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5.3. Materials and Methods 
Materials.  All chemicals were purchased and used without further purification from Sigma-
Aldrich (St. Louis, MO), unless specified.  Oligonucleotides were obtained from Integrated DNA 
Technologies (Coralville, IA).  SfiI and T4 DNA ligase were purchased from New England 
Biolabs (Ipswich, MA).  BLR(DE3) E. coli cells were purchased from Novagen (Billerica, MA).  
Isopropyl β-D-1-thiogalactopyranoside (IPTG) was purchased from Promega (Madison, WI). 
Cloning.  Forward primer TP49 was used to amplify the eCPX gene from the pB33eCPX vector 
(Plasmid 23336; Addgene, Cambridge, MA) with reverse primer TP50, TP57, TP58, or TP59, 
which fused the D20, FLAG, GPA, or FLK peptide, respectively, to the C-terminus of the eCPX 
protein with a linker (N-GGQSGQ-C).  The oligonucleotides also fused a FLAG tag to the D20, 
GPA, and FLK peptides with a linker (N-GGGS-C).  Thus, the constructs created were of the 
form: eCPX-GGQSGQ-peptide-GGGS-FLAG, as shown in Figure 5-1.  The only exception was 
the construct made using TP49/TP57, which contained no peptide, but did contain the FLAG tag.  
This construct was of the form: eCPX-GGQSGQ-FLAG.  The oligonucleotide sequences can be 
seen in Table S5-1 along with the amino acids sequences of each peptide.  The amplified 
fragments and pB33eCPX vector were digested with SfiI, gel extracted, and ligated together.  
The plasmid was electroporated into BLR(DE3) cells and selected on agar plates supplemented 
with 35µg/mL chloramphenicol.  The pB33eCPX-GPA plasmid was also transformed into BLR-
pCab and BLR-pCam cells and selected on agar plates containing 35 µg/mL chloramphenicol 
(Cm) and 50µg/mL kanamycin (Kan). 
Expression.  Protein expression was performed at 37
o
C in 10mL of Luria Broth (LB) 
supplemented with the appropriate antibiotic(s).  For cells expressing CA and eCPX 
simultaneously, 1mM ZnCl2 was also added to the media.  A 1:50 dilution of an overnight 
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culture was induced with 0.04% L-arabinose at OD600nm=0.6.  If present, CA was induced 
simultaneously with 200µM IPTG.  After 4 hours of expression, the cells were harvested by 
centrifugation at 5000xg for 5min.  The pellets were resuspended in 1M Tris pH 9.0, henceforth 
referred to as T9. 
Precipitation Assay.  The precipitation assay used was a modification to an assay previously 
described [142].  Briefly, CO2 was bubbled through 5mL of T9 containing the whole-cell 
biocatalyst in for 30s.  CaCl2 (0.5mL of 0.5g/mL in T9) was immediately added to the tube.  
After 1 hour at 25
o
C, the precipitate was separated from the solution and dried on a vacuum 
manifold (Qiagen, Valencia, CA) using spin columns (Epoch Life Science, Sugarland, TX).  The 
mass of precipitate formed was calculated by subtracting the masses of the empty column and 
cells added, which are determined before bubbling,  from the final mass of the column. 
Overall Formation Rate Assay.  Whole-cell biocatalysts were diluted to an OD600nm=0.3 in T9.  
In a 1cm cuvette, 1mL of this suspension was mixed with 1 mL of 3M CaCl2 in T9.  The cuvette 
was placed in a Jasco J-815 CD Spectrometer (JASCO, Easton, MD) fitted with a Peltier 
temperature control stage (set to 25
o
C with stirring) and monochromator.  After adding 1mL of 
CO2-saturated ddH2O to the cuvette, the absorbance at 600nm was monitored for 10min.  The 
resulting curves were fit to the Hill equation, as described in section 3.3. 
Statistical Analysis.  Analysis of variance (ANOVA) using the General Linear Model and post-
hoc analysis using the Tukey method were performed using the Minitab program (Minitab, Inc., 
State College, PA). 
5.4. Results 
eCPX Expression.  The FLAG, D20, GPA, and FLK peptides were all successfully fused to the 3’ 
end of the eCPX gene and confirmed by DNA sequencing.  All constructs followed the scheme 
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shown in Figure 5-1.  The FLAG peptide was fused to the D20, GPA, and FLK peptides for 
confirmation of expression.  All fusions were made to the C-terminus of the eCPX protein so that 
only fully expressed and translocated fusions would result in surface-displayed peptide.  All 4 
plasmids were electroporated into BLR(DE3) cells.  After transformation, the FLAG, GPA, and 
FLK peptides were all successfully expressed, as confirmed by flow cytometry (Figure S5-1).  
Under the conditions tested, the D20 peptide was not found to be displayed on the surface of the 
cells as determined by the lack of detection of the FLAG peptide.  This may be due to 
inefficiencies with translocation of poly-aspartic acid through the inner and outer membranes.  
For BLR-pCab and BLR-pCam cells transformed with the pB33eCPX-GPA plasmid, PCR 
amplification was used to verify the presence of both plasmids.  Expression of eCPX was again 
confirmed by flow cytometry (Figure S5-2).  The biocatalysts generated were called BLR-FLAG, 
BLR-GPA, BLR-FLK, BLR-pCab/GPA, and BLR-pCam/GPA.  Expression was selectively 
induced by using L-arabinose for the eCPX fusions, and IPTG for the CAs. 
CaCO3 Precipitation.  The amount of calcite precipitate formed in the presence of the 3 surface-
displayed peptides evaluated can be seen in Figure 5-2A.  This assay measured the amount of 
hydrated CO2 that can be converted to calcite by the various immobilized peptides.  Native BLR 
cells, BLR-FLAG, BLR-GPA, and BLR-FLK cells generated 0.08, 0.11, 0.11, and 0.09 g of 
CaCO3, respectively.  ANOVA on this data showed no statistically significant difference 
between BLR and BLR-FLK cells, as expected due to the positive charge of the FLK peptide.  
This analysis also revealed no statistically significant difference between BLR-FLAG and BLR-
GPA cells, both of which were significantly better than BLR cells.  Thus, the GPA peptide was 
selected for further experimentation. 
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The amount of precipitate formed in the presence of the whole-cell biocatalysts with and without 
surface-displayed GPA can be seen in Figure 5-2B.  Using BLR cells, the GPA peptide increased 
the amount of calcite formed by 38% over unmodified cells.  Similarly, display of the GPA 
peptide in BLR-pCab and BLR-pCam cells enhanced precipitation by 36% and 59%, 
respectively, over their unmodified counterparts.  Two-way ANOVA on this data revealed that 
the GPA peptide and recombinant CA each had a statistically significant impact on the amount 
of calcite precipitated.  Further, this analysis also showed a statistically significant difference 
between the cells expressing both the GPA peptide and CA, and those possessing one or none of 
these modifications.  However, neither factor was a greater contributor to the improvement in 
precipitation than the other; both were necessary to achieve the maximum enhancement. 
CaCO3 Formation Rates 
As a proxy for direct measurement of precipitation rates, the solution turbidity against time was 
measured.  Although methods exist that can specifically measure calcium ion concentrations 
within a solution, such methods can be noisy and are highly dependent on the calibration method 
used.  Thus, turbidity was used as a quick and simple method for tracking solids formation and 
this was accomplished by measuring the absorbance at 600 nm.  In this method, the absorbance 
at 600 nm was used as an indicator of solids formation.  To quantify the rate of turbidity change, 
the raw absorbance data was fit to the sigmoidal Hill equation below [208]: 
             
          
 
  
    
 (1) 
where A600 is the absorbance at 600nm, (A600)0 is the initial absorbance, (A600)Amp is the amplitude 
of the absorbance change, t is the time, tm is the time where the slope is the greatest, and α is the 
Hill coefficient.  An example of the raw data and fit can be seen in Figure 5-3.  The tm was 
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selected for comparison of the various samples.  A lower value in this parameter indicated an 
enhancement in formation rate since the maximum slope was achieved at an earlier time. 
The results of this analysis can be seen in Table 5-1.  From this experiment, a 5% reduction in tm 
was observed upon expression of GPA on BLR cells.  In BLR-pCab and BLR-pCam cells, the 
respective tm’s were reduced by18% and 60%.  For comparison, the GPA peptide was previously 
displayed on the surface of yeast cells and was shown to improve the CaCO3 mineralization rate 
by 30% over yeast cells displaying no peptide [141].  However, these results are not directly 
comparable to those reported in this study due to differences in the experimental methods.   
Two-way ANOVA on this data showed a statistically significant difference between cells 
expressing the GPA peptide and those without any surface-displayed peptide.  It also 
demonstrated a significant difference between cells with and without recombinant CA.  Further, 
the isoform of CA had a statistically significant impact on the change in turbidity.  As above, the 
effects of recombinant CA and surface-displayed GPA were not additive; the maximum 
enhancement observed with both modifications was greater than the sum of the individual 
improvements. 
5.5. Discussion 
Synthetic biology is rapidly gaining interest due to the opportunity it presents to design and 
implement biological systems in research and industrial applications.  In this work, we created 
novel whole-cell biocatalysts for carbon mineralization, an emerging technology with the 
potential for a significant environmental impact.  We show improved precipitation of calcium 
carbonate through surface-display of small peptides on E. coli cells containing periplasmically-
expressed CA enzymes.  In doing so, we demonstrate the incorporation of multiple genetic 
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modifications can be used to significantly enhance the functional activity of a whole-cell 
biocatalyst. 
Four peptide sequences were evaluated, and the cells expressing the GPA peptide were found to 
produce the highest amount of calcite precipitation.  Interestingly, the amount was not 
significantly different from what was seen with the cells expressing the FLAG sequence alone, 
which was included as a negative control.  This result was surprising since the FLAG tag had not 
been previously identified as a potential peptide for precipitation enhancement.  However, given 
its aspartic acid content (62.5%), it is not completely unexpected.  It is also interesting to note 
that when fused to another peptide, namely the GPA or FLK peptides, the FLAG tag does not 
seem to enhance the precipitation capabilities of the peptide.  For example, if the FLAG tag 
conferred an improvement in precipitation, a significant difference between BLR-FLK cells and 
BLR cells would be expected.  We speculate that when it is farther from the surface of the cell, 
the FLAG tag can experience a wider variety of conformations, causing the probability of 
binding a calcium ion to be decreased.  However, when expressed alone it is not as flexible and 
is able to facilitate CaCO3 formation. 
The results demonstrate that the immobilization of the GPA peptide on the surface of BLR-pCab 
and BLR-pCam cells yielded the best-performing whole-cell biocatalysts and there may be 
several reasons for the observed improvements.  Since precipitate growth is relatively 
spontaneous (mostly dependent on saturation conditions of the solution), supersaturation and 
nucleation are most likely the rate-limiting steps of precipitation.  In our biocatalysts, the 
surface-displayed GPA peptide could enhance nucleation of CaCO3, resulting in the onset of 
precipitation.  We speculate that immobilization of the unstructured peptides on the cell surface 
could cause a reduction in the entropic flexibility of the peptide.  With one end fixed, the number 
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of conformations available to the peptide are limited, which may increase the probability of a 
peptide-calcium interaction.  This interaction could then cause the nucleation of initial calcite 
crystals upon which subsequent molecules can deposit.   
Further, given that the enzymes are located inside the periplasm, it can be assumed that the 
highest concentration of carbonate ions would be near the surface of the cell.  Thus, 
immobilizing the GPA peptide at the cell surface likely positions it in a region with 
supersaturation above that of the bulk conditions.  With nucleation and growth occurring in close 
proximity to the CA catalysts of the system, transport distances are reduced which translates into 
an improvement in the overall formation rate, as indicated by a lower tm in our analysis above. 
A significant advantage to using whole cell systems for biotransformations is the low cost, as 
there is no need to purify the enzymes or the peptides for subsequent applications.  However 
there are a few potential limitations of this approach. For example, peptide stability could be 
problematic in various environmental conditions, especially at high pH.  And blocking of the 
peptides could occur as calcite crystals form near the surface of the cell.  
Future work on this technology could include scale-up of the experiments to bench- or pilot-scale 
reactors.  These experiments would provide some insight as to the feasibility of incorporation 
into an actual process.  And, in-depth characterization of the structure of the crystals formed with 
and without the biocatalysts present would be an interesting next step.  This could serve to 
identify alternate uses for the surface-displayed peptides in terms of manipulating the 
morphology of the precipitated CaCO3. 
5.6. Conclusions 
The use of whole cell biocatalysts in carbon mineralization processes is being explored and these 
cells can be engineered to facilitate several steps in this process.  We have previously 
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demonstrated that periplasmic expression of CA enzymes can enhance CO2 hydration, and here 
we show that the concomitant addition of the GPA peptide can also enhance calcite precipitation 
amounts and rates.  By localizing the peptides to the surface of the cells, the peptides are likely 
operating in a region of high supersaturation leading to increased performance.  The whole cells 
will be attractive new biocatalysts for carbon sequestrion and this work further demonstrates the 
power of synthetic biology for making improved biocatalytic systems. 
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5.8. Figures and Tables 
 




General schematic of eCPX constructs generated.  The N-terminus of the eCPX protein was left 
unaltered, with all fusions made to the C-terminus of the protein.  The linker L1 (N-GGQSGQ-
C) was used between eCPX and the D20, GPA, and FLK peptides.  The L2 linker (N-GGGS-C) 
was inserted between the peptides and the FLAG tag, which was used to confirm expression of 
the fusion.  For the construct containing only the FLAG tag without a peptide, FLAG was fused 










Mass of CaCO3 precipitated in presence of (A) BLR cells with no peptide, FLAG, GPA, or FLK 
surface-displayed and in the presence of (B) BLR, BLR-pCab, and BLR-pCam cells with and 
without surface-displayed GPA peptide.  All measurements were performed at least in triplicate, 
and the error bars represent the standard deviations from the mean values. 










CaCO3 precipitation measured by the absorbance at 600 nm ( ) and the Hill Equation fit to the 
data ( ) against time for one replicate using BLR cells.  Similar curves were obtained and fit 
in the same manner for BLR, BLR-GPA, BLR-pCab, BLR-pCab/GPA, BLR-pCam, and BLR-





Table 5-1 - tm for various whole-cell biocatalysts evaluated 
 
Whole-Cell Biocatalyst GPA tm (min) 
BLR - 6.3 ± 0.2 
BLR + 6.0 ± 0.3 
BLR-pCab - 5.6 ± 0.3 
BLR-pCab + 4.6 ± 0.2
a
 
BLR-pCam - 5.5 ± 0.4 




tm = Time required to achieve maximum rate of turbidity change 
All measurements were performed in triplicate and errors represent the standard deviations from 
the means 
a








5.9. Supplementary Information 
Table S5-1 - Oligonucleotide sequences for eCPX cloning 
 
Oligonucleotide Description Sequence 
TP49 eCPX Forward Primer 
5’-TCG CAA CTC TCT ACT GTT TCT 
CCA TAC CCG-3’ 
TP50 
Reverse Ultramer (FLAG) 
(N-DYKDDDDK-C) 
5’-AGT CAG GGC CAC CTT GGC CTT 
ATT ATT TGT CAT CAT CGT CTT TAT 
AAT CCT GGC CGC TCT GGC CGC CGC 




Reverse Ultramer (D20-FLAG) 
(N-(D)20-C) 
5’-AGT CAG GGC CAC CTT GGC CTT 
ATT ATT TGT CAT CAT CGT CTT TAT 
AAT CGC TGC CGC CGC CAT CGT CAT 
CGT CAT CAT CGT CAT CGT CAT CAT 
CGT CAT CGT CAT CAT CGT CAT CGT 
CAT CCT GGC CGC TCT GGC CGC CGC 
TTG CAG TAC GGC TTT TCT CGG TGT 
AA-3’ 
TP58 
Reverse Ultramer (GPA-FLAG) 
(N-PEVPEGAFDTAI-C) 
5’-AGT CAG GGC CAC CTT GGC CTT 
ATT ATT TGT CAT CAT CGT CTT TAT 
AAT CGC TGC CGC CGC CAA TCG CGG 
TAT CAA ACG CGC CTT CTG GCA CTT 
CCG GCT GGC CGC TCT GGC CGC CGC 




Reverse Ultramer (FLK-FLAG) 
(N-(FLK)4-C) 
5’-AGT CAG GGC CAC CTT GGC CTT 
ATT ATT TGT CAT CAT CGT CTT TAT 
AAT CGC TGC CGC CGC CTT TCA GGA 
ACT TGA GAA ATT TCA GGA ATT TCA 
GAA ACT GGC CGC TCT GGC CGC CGC 




TP49 does not contain a recognition site for SfiI.  This is because it is upstream of the eCPX 
gene and the 5’ SfiI recognition site in the plasmid.  The SfiI recognition sites in TP43, TP57, 





Figure S5-1 - Flow cytometry confirming expression of peptides 
 
 
Flow cytometry of cells labeled with anti-FLAG-FITC conjugated monoclonal antibody.  After 
expression, 0.5 mL of the cell culture was centrifuged at maximum speed (13000 rpm) for 1 
minute.  The pellet was then washed 2 times with 1xPBS by resuspending the cells in the buffer 
and then pelleting them via centrifugation.  The washed pellet was resuspended in 0.5 mL 1xPBS 
supplemented with 2.5 µL of the antibody and 5 µL of 100xBSA.  After incubation at room 
temperature for 20 minutes with gentle agitation, the cells were washed twice with 1xPBS.  The 
washed pellet was resuspended in 2 mL of 1xPBS and analyzed on a FACSCanto II Flow 
Cytometer (BD Biosciences, Franklin Lakes, NJ).  (A) BLR, (B) BLR-FLAG, (C) BLR-GPA, 









Flow cytometry of (A) BLR, (B) BLR-GPA, (C) BLR-pCab/GPA, and (D) BLR-pCam/GPA 




Figure S5-3 - CaCO3 Formation Rate Data for BLR cells 
 
Turbidity (Abs @ 600 nm) against time (solid lines) and Hill fits (dashed lines). 
Figure S5-4 - CaCO3 Formation Rate Data for BLR-GPA cells 
 
Turbidity (Abs @ 600 nm) against time (solid lines) and Hill fits (dashed lines). 
Figure S5-5 - CaCO3 Formation Rate Data for BLR-pCab cells 
 




Figure S5-6 - CaCO3 Formation Rate Data for BLR-pCab/GPA cells 
 
Turbidity (Abs @ 600 nm) against time (solid lines) and Hill fits (dashed lines). 
Figure S5-7 - CaCO3 Formation Rate Data for BLR-pCam cells 
 
Turbidity (Abs @ 600 nm) against time (solid lines) and Hill fits (dashed lines). 
Figure S5-8 - CaCO3 Formation Rate Data for BLR-pCam/GPA cells 
 




6. Summary and Future Work 
 
6.1. Summary 
In this dissertation we have outlined our efforts towards understanding and engineering 
heterogeneous biocatalysis using two different enzyme immobilization techniques.  
Heterogeneous biocatalysis provides many advantages over homogeneous biocatalysis including 
enhanced stability, improved recyclability, and reduced cost.  Each of these benefits contributes 
to the attractiveness of these biocatalysts for both research and industrial applications. 
In Chapter 1, we examined the governing principles and current literature behind two enzyme 
immobilization techniques: adsorption to a solid surface and whole-cell biocatalysis.  We began 
by discussing the link between protein folding and surface adsorption, in that the same forces 
that contribute to protein folding are also responsible for allowing a protein to adsorb onto a 
surface.  In both cases, the goal is to minimize the Gibbs Free Energy of the system.  The current 
literature in this field has examined adsorption behavior, desorption behavior, the effects of 
particle curvature, and the effects of engineered thermal stability, among other topics.  We felt 
there was a gap in this body of work, in which naturally-evolved proteins with similar structures 
but vastly different thermal stabilities were used.  As such, we described a system in which 
AdhD and hAR, two members of the AKR superfamily could be used to explore just that. 
Further into Chapter 1, we discussed several techniques by which an enzyme could be 
immobilized onto or within the host cell in which it was expressed.  One of the major advantages 
to this approach is that protein purification is not required since immobilization is often 
performed in parallel with expression.  Cytosolic expression, periplasmic expression, and surface 
display were all examined as possibilities, with advantages and disadvantages to each provided.  
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Due to these comparisons, periplasmic expression was selected as the immobilization modality 
for this work.  The enzyme selected as a model for this work was carbonic anhydrase, a family of 
Zn
+2
-binding metalloenzymes capable of catalyzing the reversible hydration of CO2.  From this 
family, 2 were selected, namely Cab and Cam, for their individual characteristics that could 
prove beneficial to the generation of an efficient, stable whole-cell biocatalyst. 
In Chapter 2, we addressed the gap in current adsorption literature described above.  Using 
AdhD and hAR, we were able to determine how adsorption behavior varies with intrinsic native 
stability, as opposed to engineered stability.  From this work, it was determined that even a 
protein with extremely high thermal stability (AdhD) is susceptible to significant surface-
induced structural rearrangement, regardless of surface coverage.  This surprisingly coincided 
with hAR’s adsorption behavior, so much so that both proteins exhibited similar structures in 
their respective adsorbed states.  Conversely, their desorption behaviors did vary.  AdhD, while 
never returning to native form, regained the same amount of structure and activity upon 
desorption in a surface coverage-independent manner.  The properties of desorbed hAR, however, 
were dependent on surface coverage such that proteins desorbed from lower coverages refolded 
to a lesser degree and thus exhibited slower kinetics relative to native enzyme.  From these 
findings we concluded there is less correlation between thermostability and adsorption behavior 
than previously thought. 
As an alternative to adsorption, whole-cell biocatalysis was explored, beginning with Chapter 3.1.  
Cab and Cam were periplasmically expressed using the gIII and pelB periplasmic leader peptides.  
The pelB system showed higher expression levels and whole-cell kinetics for both enzymes.  
There was no difference in activity retention after 24 hours between the two peptides.  There was 
also no observed difference in the amount of carbonate precipitated in the presence of cells 
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harboring CA.  Finally, the whole-cell biocatalysts containing Cab were more stable than 
purified Cab, retaining almost 100% of their native activity at 95
o
C.  A similar result was seen 
with BLR-gCam, but BLR-pCam did not follow this trend, losing about 35% of its native 
activity at 95
o
C.  We hypothesized that in cells expressing pCam, there was some amount of 
membrane perturbation that increased the overall reaction rate (BLR-pCam exhibited the highest 
activity of the 4 whole-cell biocatalysts), but also reduced the stabilizing effects of 
immobilization.  These experiments showed that we were able to successfully create and 
characterize heterogeneous biocatalysts in the form of whole-cells.  However, for complete 
characterization, there was still one parameter missing: operational stability. 
In current literature, there are several methods by which to measure the operational stability of a 
biocatalyst.  However, CA-based biocatalysts are much more difficult to characterize by these 
methods so we took it upon ourselves to develop a new method for this purpose.  In Chapter 3.2, 
we presented a repeated-batch method that employed automatic switching between the forward 
and reverse reactions for CA-based biocatalysts.  In this way, the activity of the biocatalysts was 
tracked over time and used to determine the operational stability.  This data was used to calculate 
the half-lives of both homogeneous and heterogeneous biocatalysts with CA activity.  Cab was 
found to have the longest half-life of the purified enzymes, and all 4 of the whole-cell 
biocatalysts evaluated were stable for far longer than the limit of stable operation for the method, 
further supporting the theory of enzyme stabilization upon immobilization. 
Moving forward from simply characterizing the whole-cell biocatalysts, we sought to introduce 
modifications to the cells to improve their kinetic and functional activities.  In Chapter 4, the 
envelope protein from SARS coronavirus was recombinantly expressed in the biocatalysts.  This 
protein (SCVE) was previously shown to permeabilize the outer membranes of E. coli cells.  
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Upon expression, SCVE increased outer membrane permeability to a small molecule (NPN) and 
improved the overall reaction rate of CO2 hydration in the presence of the biocatalysts.  After 
characterization, the , , De, and P for both the unmodified and modified biocatalysts were 
calculated and compared.  This analysis showed an approximate doubling in effectiveness factor, 
and halving of the Thiele modulus. 
The second modification to the whole-cell biocatalysts was to express Ca
+2
-binding peptides on 
the outer surface of the cells using the eCPX system.  This work was described in Chapter 5.  
The eCPX protein is a modified version of the OmpX transmembrane protein such that its 
termini are exposed to the extracellular space.  Several peptides were fused to the exposed C-
terminus and evaluated for their ability to precipitate CaCO3.  We found that surface-displayed 
GPA peptide in conjunction with periplasmic CA generated the most precipitate, and also 
significantly enhanced the calcite precipitation rate in the presence of our whole-cell biocatalysts. 
6.2. Future Work 
Although we were able to accomplish a considerable amount surrounding heterogeneous 
biocatalysts, there is always the opportunity to expand upon the work completed.  In this final 
section of this dissertation, we present some areas for further exploration in order to gain further 
understanding of immobilization, or to engineer even better biocatalysts. 
Area 1: Combined effects of thermal stability and surface properties on adsorption 
behavior 
In order to supplement the work performed using AdhD and hAR, we believe that performing 
these same experiments on more substrates would provide additional information as to the full 
impact of intrinsic thermal stability on adsorption behavior.  As discussed in Chapter 1, groups 
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have explored the effects of surface curvature on the structural rearrangement of adsorbed 
protein molecules.  However, perhaps the impact of curvature are not as pronounced for proteins 
with higher native thermostability.  Also, determining the effects of surfaces with varying 
charges or hydrophobicities would further characterize the adsorption behaviors of proteins with 
different thermal stabilities. 
Area 2: Combining whole-cell modifications to improve overall functionality 
In Chapters 4 and 5, we examined outer membrane permeabilization and outer membrane 
functionalization, respectively.  These modifications were shown to improve the kinetic and 
functional activities when used individually.  Perhaps combining these two systems into one 
whole-cell biocatalyst would provide an additional benefit that is greater than the sum of the two 
parts individually.  Given the changes observed in the presence of each modification, it is not 
unreasonable to assume that improving the kinetic activity and precipitation capabilities of a 
whole-cell biocatalyst would yield the greatest improvement over the unmodified biocatalyst. 
Area 3: Engineering whole-cells as analogs for metabalons 
In biochemical pathways, metabolons are complexes of enzymes in which each enzyme is 
responsible for a specific segment of the pathway [209-211].  These complexes can involve any 
number of enzymes, depending on the complexity of the pathway.  Most commonly, these 
metabolons are formed by fusing the various proteins together [212, 213].  However, using what 
we have learned about whole-cell biocatalysis, we believe that a cell could be used as a scaffold 
for metabolon formation.  By co-expressing multiple proteins in a single cell, we could introduce 
novel function to the cell to bring a metabolic pathway to completion.  Further, the cell provides 
the unique opportunity of being able to compartmentalize the enzymes such that we could have 
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enzymes in the cytosol, periplasm, and exposed to the extracellular matrix to drive the reaction 
from within the cell towards secretion, or vice versa.  To catalyze a biochemical reaction, this 
scheme would allow us to take advantage of the concept of substrate channeling [214], in which 
the intermediates of a reaction are shuttled from one enzyme to another along the conversion 
pathway. 
Creating a metabolon within the cell also would allow us to harness the differences in various 
promoters to our advantage.  By placing more active enzymes under weaker promoters and less 
active enzymes under stronger promoters, the disparity in kinetics could be normalized so that 
the reaction is as close to equilibrium as possible.  Using these principles and techniques, we 
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